,Trade Name,Generic/Proper Name(s),Active Ingredient(s),DICT _ Concern,Standardized_SMILES,Standardized_InChI,DICTrank,name,Cardiotoxicity,CT label
0,anzemet,dolasetron mesylate,dolasetron mesylate,most,O=C(OC1CC2CC3CC(C1)[NH+]2CC3=O)c1c[nH]c2ccccc12,"InChI=1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/p+1",1,dolasetron mesylate,Arrhythmia,wp
1,trazodone hydrochloride,trazodone hydrochloride,trazodone hydrochloride,most,O=c1n(CCC[NH+]2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2/p+1",1,trazodone hydrochloride,Mixed,wp
2,nuplazid,pimavanserin tartrate,pimavanserin tartrate,most,CC(C)COc1ccc(CNC(=O)[NH+](Cc2ccc(F)cc2)C2CC[NH+](C)CC2)cc1,"InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)/p+2",1,pimavanserin tartrate,Arrhythmia,wp
3,metformin hydrochloride,metformin hydrochloride,metformin hydrochloride,most,C[NH+](C)C([NH3+])=NC(N)=[NH2+],"InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)/p+3",1,metformin hydrochloride,Mixed,bw
4,flurbiprofen,flurbiprofen,flurbiprofen,most,CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/p-1",1,flurbiprofen,Heart Damage,bw
5,ketoprofen,ketoprofen,ketoprofen,most,CC(C(=O)[O-])c1cccc(C(=O)c2ccccc2)c1,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/p-1",1,ketoprofen,Heart Damage,bw
6,loperamide hydrochloride,loperamide hydrochloride,loperamide hydrochloride,most,C[NH+](C)C(=O)C(CC[NH+]1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,"InChI=1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3/p+2",1,loperamide hydrochloride,Arrhythmia,bw
7,amitriptyline hydrochloride,amitriptyline hydrochloride,amitriptyline hydrochloride,most,C[NH+](C)CCC=C1c2ccccc2CCc2ccccc21,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3/p+1",1,amitriptyline hydrochloride,Mixed,wp
8,methamphetamine hydrochloride,methamphetamine hydrochloride,methamphetamine hydrochloride,most,C[NH2+]C(C)Cc1ccccc1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/p+1",1,methamphetamine hydrochloride,Mixed,bw
9,ketoconazole,ketoconazole,ketoconazole,most,CC(=O)[NH+]1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,"InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/p+1",1,ketoconazole,Arrhythmia,bw
10,omnipaque,iohexol,iohexol,most,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,"InChI=1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)",1,iohexol,Mixed,bw
11,visipaque,iodixanol,iodixanol,most,CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,"InChI=1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62)",1,iodixanol,Mixed,bw
12,sertraline,sertraline,sertraline hydrochloride,most,C[NH2+]C1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,"InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/p+1",1,sertraline,Arrhythmia,wp
13,ondansetron,ondansetron,ondansetron hydrochloride,most,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,"InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3",1,ondansetron,Arrhythmia,wp
14,praziquantel,praziquantel,praziquantel,most,O=C(C1CCCCC1)[NH+]1CC(=O)[NH+]2CCc3ccccc3C2C1,"InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2/p+2",1,praziquantel,Arrhythmia,wp
15,cilostazol,cilostazol,cilostazol,most,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,"InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)",1,cilostazol,Mixed,wp
16,thalomid,thalidomide,thalidomide,most,O=C1CCC([NH+]2C(=O)c3ccccc3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/p+1",1,thalidomide,Mixed,wp
17,estropipate,estropipate,estropipate,most,CC12CCC3c4ccc(OS(=O)(=O)[O-])cc4CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/p-1",1,estropipate,Heart Damage,bw
18,kynmobi,apomorphine hydrochloride,apomorphine hydrochloride,most,C[NH+]1CCc2cccc3c2C1Cc1ccc([O-])c([O-])c1-3,"InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/p-1",1,apomorphine hydrochloride,Mixed,wp
19,iclusig,ponatinib hydrochloride,ponatinib hydrochloride,most,Cc1ccc(C(=O)Nc2ccc(C[NH+]3CC[NH+](C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,"InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)/p+2",1,ponatinib hydrochloride,Mixed,bw
20,scemblix,asciminib,asciminib hydrochloride,most,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CCC(O)C2)c(-c2cc[n-]n2)c1,"InChI=1S/C20H18ClF2N5O3/c21-20(22,23)31-15-3-1-13(2-4-15)26-19(30)12-9-16(17-5-7-25-27-17)18(24-10-12)28-8-6-14(29)11-28/h1-5,7,9-10,14,29H,6,8,11H2,(H2,25,26,27,30)/p-1",1,asciminib,Mixed,wp
21,,terfenadine,terfenadine,most,CC(C)(C)c1ccc(C(O)CCC[NH+]2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,"InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3/p+1",1,terfenadine,Arrhythmia,Withdraw
22,granisetron hydrochloride,granisetron hydrochloride,granisetron hydrochloride,most,Cn1nc(C(=O)NC2CC3CCCC(C2)[NH+]3C)c2ccccc21,"InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/p+1",1,granisetron hydrochloride,Arrhythmia,wp
23,wakix,pitolisant hydrochloride,pitolisant hydrochloride,most,Clc1ccc(CCCOCCC[NH+]2CCCCC2)cc1,"InChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2/p+1",1,pitolisant hydrochloride,Arrhythmia,wp
24,ziprasidone hydrochloride,ziprasidone hcl,ziprasidone hydrochloride,most,[O-]c1cc2cc(CC[NH+]3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2[n-]1,"InChI=1S/C21H20ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11-13,27H,5-10H2/q-1",1,ziprasidone hcl,Mixed,wp
25,procainamide hydrochloride,procainamide hydrochloride,procainamide hydrochloride,most,CC[NH+](CC)CCNC(=O)c1ccc(N)cc1,"InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)/p+1",1,procainamide hydrochloride,Arrhythmia,bw
26,ibuprofen,ibuprofen,ibuprofen,most,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/p-1",1,ibuprofen,Heart Damage,bw
27,,sibutramine,sibutramine,most,CC(C)CC([NH+](C)C)C1(c2ccc(Cl)cc2)CCC1,"InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3/p+1",1,sibutramine,Heart Damage,Withdraw
28,maraviroc,maraviroc,maraviroc,most,Cc1nnc(C(C)C)n1C1CC2CCC(C1)[NH+]2CCC(NC(=O)C1CCC(F)(F)CC1)c1ccccc1,"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/p+1",1,maraviroc,Heart Damage,wp
29,quinidine sulfate,quinidine sulfate tablet,quinidine sulfate,most,C=CC1C[NH+]2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,"InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/p+1",1,quinidine sulfate tablet,Arrhythmia,wp
30,propofol,propofol,propofol,most,CC(C)c1cccc(C(C)C)c1[O-],"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3/p-1",1,propofol,Mixed,wp
31,maxaquin,lomefloxacin hydrochloride,lomefloxacin hydrochloride,most,CCn1cc(C(=O)[O-])c(=O)c2cc(F)c(N3CC[NH2+]C(C)C3)c(F)c21,"InChI=1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)",1,lomefloxacin hydrochloride,Arrhythmia,wp
32,dopram,doxapram hydrochloride,doxapram hydrochloride,most,CC[NH+]1CC(CC[NH+]2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,"InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3/p+2",1,doxapram hydrochloride,Arrhythmia,wp
33,kyprolis,carfilzomib,carfilzomib,most,CC(C)CC(NC(=O)C(CCc1ccccc1)NC(=O)C[NH+]1CCOCC1)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1,"InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/p+1",1,carfilzomib,Mixed,wp
34,velcade,bortezomib,bortezomib,most,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)",1,bortezomib,Mixed,wp
35,pregabalin,pregabalin,pregabalin,most,CC(C)CC(C[NH3+])CC(=O)[O-],"InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)",1,pregabalin,Arrhythmia,wp
36,sunitinib malate,sunitinib malate,sunitinib malate,most,CC[NH+](CC)CC=NC(=O)c1c(C)[nH]c(Cc2c([O-])[n-]c3ccc(F)cc23)c1C,"InChI=1S/C22H26FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-9,11,28H,5-6,10,12H2,1-4H3,(H,25,29)/q-1",1,sunitinib malate,Mixed,wp
37,ritonavir,ritonavir,ritonavir,most,CC(C)c1nc(C[NH+](C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/p+1",1,ritonavir,Mixed,wp
38,,probucol,probucol,most,CC(C)(Sc1cc(C(C)(C)C)c([O-])c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c([O-])c(C(C)(C)C)c1,"InChI=1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3/p-2",1,probucol,Arrhythmia,Withdraw
39,hydrocodone bitartrate,hydrocodone bitartrate,hydrocodone bitartrate,most,COc1ccc2c3c1OC1C(=O)CCC4C(C2)[NH+](C)CCC314,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/p+1",1,hydrocodone bitartrate,Mixed,wp
40,,phentermine,phentermine,most,CC(C)([NH3+])Cc1ccccc1,"InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3/p+1",1,phentermine,Heart Damage,Withdraw
41,mitoxantrone,mitoxantrone,mitoxantrone hydrochloride,most,[O-]c1ccc([O-])c2c([O-])c3c(NCC[NH2+]CCO)ccc(NCC=NCCO)c3c([O-])c12,"InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-5,24-32H,6-12H2/p-3",1,mitoxantrone,Heart Damage,bw
42,,chlorphentermine,chlorphentermine,most,CC(C)([NH3+])Cc1ccc(Cl)cc1,"InChI=1S/C10H14ClN/c1-10(2,12)7-8-3-5-9(11)6-4-8/h3-6H,7,12H2,1-2H3/p+1",1,chlorphentermine,Heart Damage,Withdraw
43,macrilen,macimorelin acetate,macimorelin,most,CC(C)([NH3+])C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1c[nH]c2ccccc12)NC=O,"InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/p+1",1,macimorelin acetate,Arrhythmia,wp
44,hydroxyzine hydrochloride,hydroxyzine hydrochloride,hydroxyzine dihydrochloride,most,OCCOCC[NH+]1CC[NH+](C(c2ccccc2)c2ccc(Cl)cc2)CC1,"InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2/p+2",1,hydroxyzine hydrochloride,Arrhythmia,wp
45,albuterol,albuterol,albuterol,most,CC(C)(C)[NH2+]CC(O)c1ccc([O-])c(CO)c1,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",1,albuterol,Mixed,wp
46,oxaliplatin,oxaliplatin,oxaliplatin,most,[NH3+]C1CCCCC1[NH3+],"InChI=1S/C6H14N2/c7-5-3-1-2-4-6(5)8/h5-6H,1-4,7-8H2/p+2",1,oxaliplatin,Arrhythmia,wp
47,asenapine,asenapine maleate,asenapine maleate,most,C[NH+]1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,"InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/p+1",1,asenapine maleate,Mixed,wp
48,carbamazepine,carbamazepine,carbamazepine,most,NC(=O)N1c2ccccc2C=Cc2ccccc21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",1,carbamazepine,Arrhythmia,wp
49,thioridazine hydrochloride,thioridazine hydrochloride,thioridazine hydrochloride,most,CSc1ccc2c(c1)N(CCC1CCCC[NH+]1C)c1ccccc1S2,"InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3/p+1",1,thioridazine hydrochloride,Arrhythmia,bw
50,onglyza,saxagliptin,saxagliptin hydrochloride,most,N#CC1CC2CC2[NH+]1C(=O)C([NH3+])C12CC3CC(CC(O)(C3)C1)C2,"InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/p+2",1,saxagliptin,Heart Damage,wp
51,halaven,eribulin mesylate,eribulin mesylate,most,C=C1CC2CCC34CC5OC6C(OC7CCC(CC(=O)CC8C(CC9OC(CCC1O2)CC(C)C9=C)OC(CC(O)C[NH3+])C8OC)OC7C6O3)C5O4,"InChI=1S/C40H59NO11/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41/h19,23-39,43H,2-3,5-18,41H2,1,4H3/p+1",1,eribulin mesylate,Arrhythmia,wp
52,diflunisal,diflunisal,diflunisal,most,O=C([O-])c1cc(-c2ccc(F)cc2F)ccc1[O-],"InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)/p-2",1,diflunisal,Heart Damage,bw
53,xalkori,crizotinib,crizotinib,most,CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)c[n-]c1=N)c1c(Cl)ccc(F)c1Cl,"InChI=1S/C21H21Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H-,25,27)/q-1/p+1",1,crizotinib,Arrhythmia,wp
54,braftovi,encorafenib,encorafenib,most,COC(=O)NC(C)CN=c1nc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)cc[n-]1,"InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H2,25,26,27,28,32)/p-1",1,encorafenib,Arrhythmia,wp
55,voriconazole,voriconazole,voriconazole,most,CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3",1,voriconazole,Arrhythmia,wp
56,dopamine hydrochloride,dopamine hydrochloride,dopamine hydrochloride,most,[NH3+]CCc1ccc([O-])c([O-])c1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2/p-1",1,dopamine hydrochloride,Mixed,wp
57,hydralazine hydrochloride,hydralazine hydrochloride,hydralazine hydrochloride,most,NN=c1[n-]ncc2ccccc12,"InChI=1S/C8H7N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2/q-1",1,hydralazine hydrochloride,Heart Damage,wp
58,lmd in dextrose; lmd in sodium chloride,dextran 40,dextran 40,most,O=C(C(O)CO)C(O)C(O)COC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,"InChI=1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h5-8,10-22,24-30H,1-4H2",1,dextran 40,Arrhythmia,wp
59,agrylin,anagrelide hydrochloride,anagrelide hydrochloride anhydrous,most,[O-]c1cn2c(n1)Nc1ccc(Cl)c(Cl)c1C2,"InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2,4,16H,3H2,(H,13,14)/p-1",1,anagrelide hydrochloride,Mixed,wp
60,rizatriptan benzoate,rizatriptan benzoate,rizatriptan benzoate,most,C[NH+](C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,"InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3/p+1",1,rizatriptan benzoate,Mixed,wp
61,eletriptan hydrobromide,eletriptan hydrobromide,eletriptan hydrobromide,most,C[NH+]1CCCC1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/p+1",1,eletriptan hydrobromide,Mixed,wp
62,citalopram,citalopram,citalopram hydrobromide,most,C[NH+](C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/p+1",1,citalopram,Arrhythmia,wp
63,razadyne,galantamine hydrobromide,galantamine hydrobromide,most,COc1ccc2c3c1OC1CC(O)C=C(CC[NH+](C)C2)C31,"InChI=1S/C17H21NO3/c1-18-6-5-10-7-12(19)8-14-15(10)16-11(9-18)3-4-13(20-2)17(16)21-14/h3-4,7,12,14-15,19H,5-6,8-9H2,1-2H3/p+1",1,galantamine hydrobromide,Arrhythmia,wp
64,cyclophosphamide,cyclophosphamide,cyclophosphamide anhydrous,most,O=P1([NH+](CCCl)CCCl)[NH2+]CCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)/p+2",1,cyclophosphamide,Mixed,wp
65,abacavir,abacavir,abacavir sulfate,most,N=c1[n-]c(=NC2CC2)c2ncn(C3C=CC(CO)C3)c2[n-]1,"InChI=1S/C14H16N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H-2,15,17,18,19)/q-2",1,abacavir,Heart Damage,wp
66,nitroglycerin,nitroglycerin,nitroglycerin,most,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],"InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2",1,nitroglycerin,Heart Damage,wp
67,trelstar,triptorelin pamoate,triptorelin pamoate,most,CC(C)CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc([O-])cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1cnc[n-]1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)[NH+]1CCCC1C(=O)NCC(N)=O,"InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83H,7-8,13-14,19-27,31-32H2,1-2H3,(H17,65,66,67,68,69,72,73,74,75,76,77,78,79,80,81,84,85,86,87,88,89,90,91,92,93,94)",1,triptorelin pamoate,Mixed,wp
68,xeljanz; xeljanz xr,tofacitinib,tofacitinib citrate,most,CC1CC[NH+](C(=O)CC#N)CC1[NH+](C)c1ncnc2[nH]ccc12,"InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/p+2",1,tofacitinib,Heart Damage,bw
69,depo-estradiol,estradiol cypionate,estradiol cypionate,most,CC12CCC3c4ccc([O-])cc4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/p-1",1,estradiol cypionate,Heart Damage,bw
70,midodrine hydrochloride,midodrine hydrochloride,midodrine hydrochloride,most,COc1ccc(OC)c(C(O)CNC(=O)C[NH3+])c1,"InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)/p+1",1,midodrine hydrochloride,Heart Damage,bw
71,octreotide acetate,octreotide acetate,octreotide acetate,most,CC(=O)C1NC(=O)C(CCCC[NH3+])NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C([NH3+])Cc2ccccc2)CSSCC(C(=O)NC(CO)C(C)O)[NH2+]C1O,"InChI=1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28,34,36-42,49,52,58,60-61,69H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,59,64)/p+3",1,octreotide acetate,Arrhythmia,wp
72,verapamil hydrochloride,verapamil hydrochloride,verapamil hydrochloride,most,COc1ccc(CC[NH+](C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3/p+1",1,verapamil hydrochloride,Mixed,wp
73,atomoxetine hydrochloride,atomoxetine hydrochloride,atomoxetine hydrochloride,most,C[NH2+]CCC(Oc1ccccc1C)c1ccccc1,"InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/p+1",1,atomoxetine hydrochloride,Mixed,wp
74,fluoxetine,fluoxetine hydrochloride,fluoxetine hydrochloride,most,C[NH2+]CCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3/p+1",1,fluoxetine hydrochloride,Arrhythmia,wp
75,nortriptyline hydrochloride,nortriptyline hydrochloride,nortriptyline hydrochloride,most,C[NH2+]CCC=C1c2ccccc2CCc2ccccc21,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3/p+1",1,nortriptyline hydrochloride,Arrhythmia,wp
76,avandia,rosiglitazone maleate,rosiglitazone maleate,most,CN(CCOc1ccc(Cc2sc(=O)[n-]c2[O-])cc1)c1ccccn1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9H,10-12H2,1H3,(H2,20,22,23)/p-2",1,rosiglitazone maleate,Heart Damage,bw
77,lorbrena,lorlatinib,lorlatinib,most,CC1Oc2cc(c[n-]c2=N)-c2c(nn(C)c2C#N)C[NH+](C)C(=O)c2ccc(F)cc21,"InChI=1S/C21H18FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H-,24,25)/q-1/p+1",1,lorlatinib,Mixed,wp
78,bisoprolol fumarate,bisoprolol fumarate,bisoprolol fumarate,most,CC(C)[NH2+]CC(O)COc1ccc(COCCOC(C)C)cc1,"InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3/p+1",1,bisoprolol fumarate,Heart Damage,wp
79,digoxin,digoxin,digoxin,most,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(c7coc([O-])c7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,"InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,18-21,23-31,33-38,42-48H,6-11,13-17H2,1-5H3/p-1",1,digoxin,Arrhythmia,wp
80,naratriptan,naratriptan,naratriptan hydrochloride,most,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CC[NH+](C)CC3)c2c1,"InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3/p+1",1,naratriptan,Mixed,wp
81,methylphenidate hydrochloride,methylphenidate hydrochloride,methylphenidate hydrochloride,most,COC(=O)C(c1ccccc1)C1CCCC[NH2+]1,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/p+1",1,methylphenidate hydrochloride,Mixed,wp
82,levofloxacin,levofloxacin,levofloxacin,most,CC1COc2c(N3CC[NH+](C)CC3)c(F)cc3c(=O)c(C(=O)[O-])cn1c23,"InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)",1,levofloxacin,Arrhythmia,wp
83,oxybutynin chloride,oxybutynin chloride,oxybutynin chloride,most,CC[NH+](CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,"InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/p+1",1,oxybutynin chloride,Mixed,wp
84,nicardipine hydrochloride,nicardipine hydrochloride,nicardipine hydrochloride,most,COC(=O)C1=C(C)N=C(C)C(C(=O)OCC[NH+](C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,"InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,23-24H,13-14,16H2,1-4H3/p+1",1,nicardipine hydrochloride,Heart Damage,wp
85,alvimopan,alvimopan,alvimopan,most,CC1C[NH+](CC(Cc2ccccc2)C(=O)NCC(=O)[O-])CCC1(C)c1cccc([O-])c1,"InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/p-1",1,alvimopan,Heart Damage,bw
86,,sparfloxacin,sparfloxacin,most,CC1CN(c2c(F)c(N)c3c(=O)c(C(=O)[O-])cn(C4CC4)c3c2F)CC(C)[NH2+]1,"InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)",1,sparfloxacin,Arrhythmia,Withdraw
87,xospata,gilteritinib,gilteritinib fumarate,most,CCc1nc(C(N)=O)c(=Nc2ccc(N3CCC([NH+]4CC[NH+](C)CC4)CC3)c(OC)c2)[n-]c1[NH2+]C1CCOCC1,"InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H4,30,31,32,34,38)/p+2",1,gilteritinib,Arrhythmia,wp
88,capecitabine,capecitabine,capecitabine,most,CCCCCOC(=O)N=c1[n-]c(=O)n(C2OC(C)C(O)C2O)cc1F,"InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/p-1",1,capecitabine,Mixed,wp
89,daunorubicin hydrochloride,daunorubicin hydrochloride,daunorubicin hydrochloride,most,COc1cccc2c([O-])c3c([O-])c4c(c([O-])c3c([O-])c12)=C(OC1CC([NH3+])C(O)C(C)O1)CC(O)(C(C)=O)C=4,"InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,8,10,14,17,22,30-35H,7,9,28H2,1-3H3/p-3",1,daunorubicin hydrochloride,Heart Damage,bw
90,corvert,ibutilide fumarate,ibutilide fumarate,most,CCCCCCC[NH+](CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,"InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3/p+1",1,ibutilide fumarate,Arrhythmia,wp
91,isovue 200; isovue 250; isovue 300; isovue 370,iopamidol,iopamidol,most,CC(=O)C(O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I,"InChI=1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h7-8,15,23-27,29H,2-5H2,1H3,(H,21,30)(H,22,31)",1,iopamidol,Mixed,wp
92,corlanor,ivabradine,ivabradine hydrochloride,most,COc1cc2c(cc1OC)CC(=O)[NH+](CCC[NH+](C)CC1Cc3cc(OC)c(OC)cc31)CC2,"InChI=1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/p+2",1,ivabradine,Arrhythmia,wp
93,moxifloxacin hydrochloride,moxifloxacin hydrochloride,moxifloxacin hydrochloride,most,COc1c(N2CC3CCC[NH2+]C3C2)c(F)cc2c(=O)c(C(=O)[O-])cn(C3CC3)c12,"InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)",1,moxifloxacin hydrochloride,Arrhythmia,wp
94,cartia xt,diltiazem hydrochloride,diltiazem hydrochloride,most,COc1ccc(C2Sc3ccccc3N(CC[NH+](C)C)C(=O)C2OC(C)=O)cc1,"InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/p+1",1,diltiazem hydrochloride,Mixed,wp
95,belviq xr; belviq,lorcaserin hydrochloride hemihydrate,lorcaserin hydrochloride hemihydrate,most,CC1C[NH2+]CCc2ccc(Cl)cc21,"InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/p+1",1,lorcaserin hydrochloride hemihydrate,Mixed,wp
96,phenytoin,phenytoin,phenytoin,most,O=C1[N-]C(=O)C(c2ccccc2)(c2ccccc2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)/p-1",1,phenytoin,Arrhythmia,wp
97,diethylpropion hydrochloride er,diethylpropion hydrochloride er,diethylpropion hydrochloride,most,CC[NH+](CC)C(C)C(=O)c1ccccc1,"InChI=1S/C13H19NO/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12/h6-11H,4-5H2,1-3H3/p+1",1,diethylpropion hydrochloride er,Heart Damage,wp
98,sotalol,sotalol,sotalol,most,CC(C)[NH2+]CC(O)c1ccc(NS(C)(=O)=O)cc1,"InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3/p+1",1,sotalol,Mixed,wp
99,etodolac,etodolac,etodolac,most,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)[O-])OCC3,"InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/p-1",1,etodolac,Heart Damage,bw
100,katerzia,amlodipine,amlodipine benzoate,most,CCOC(=O)C1=C(COCC[NH3+])N=C(C)C(C(=O)OC)C1c1ccccc1Cl,"InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,16-17H,4,9-11,22H2,1-3H3/p+1",1,amlodipine,Heart Damage,wp
101,flumazenil,flumazenil,flumazenil,most,CCOC(=O)c1ncn2c1C[NH+](C)C(=O)c1cc(F)ccc1-2,"InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3/p+1",1,flumazenil,Arrhythmia,wp
102,e.e.s; e.e.s 400,erythromycin ethylsuccinate,erythromycin ethylsuccinate,most,CCOC(=O)CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1[NH+](C)C,"InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/p+1",1,erythromycin ethylsuccinate,Arrhythmia,wp
103,ethyol,amifostine,amifostine,most,[NH3+]CCC[NH2+]CCS[P](=O)(=O)O,"InChI=1S/C5H14N2O3PS/c6-2-1-3-7-4-5-12-11(8,9)10/h7H,1-6H2,(H,8,9,10)/p+2",1,amifostine,Mixed,wp
104,olumiant,baricitinib,baricitinib,most,CCS(=O)(=O)[NH+]1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,"InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)/p+1",1,baricitinib,Heart Damage,bw
105,,propoxyphene,propoxyphene,most,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)C[NH+](C)C,"InChI=1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3/p+1",1,propoxyphene,Arrhythmia,Withdraw
106,ofev,nintedanib,nintedanib esylate,most,COC(=O)c1ccc2c(C(=Nc3ccc(N(C)C(=O)C[NH+]4CC[NH+](C)CC4)cc3)c3ccccc3)c([O-])[n-]c2c1,"InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19H,15-18,20H2,1-3H3,(H2,32,33,38,39)",1,nintedanib,Heart Damage,wp
107,minoxidil,minoxidil,minoxidil,most,N=c1[n-]c(N2CCCCC2)cc(N)[n+]1[O-],"InChI=1S/C9H14N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H-,11,12)/q-1",1,minoxidil,Heart Damage,bw
108,ellence,epirubicin hydrochloride,epirubicin hydrochloride,most,COc1cccc2c([O-])c3c([O-])c4c(c([O-])c3c([O-])c12)=C(OC1CC([NH3+])C(O)C(C)O1)CC(O)(C(=O)CO)C=4,"InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,7,10,13,17,22,29,31-36H,6,8-9,28H2,1-2H3/p-3",1,epirubicin hydrochloride,Mixed,bw
109,,grepafloxacin,grepafloxacin,most,Cc1c(F)c(N2CC[NH2+]C(C)C2)cc2c1c(=O)c(C(=O)[O-])cn2C1CC1,"InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26)",1,grepafloxacin,Arrhythmia,Withdraw
110,mefloquine hydrochloride,mefloquine hydrochloride,mefloquine hydrochloride,most,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCC[NH2+]1,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/p+1",1,mefloquine hydrochloride,Arrhythmia,wp
111,,etoricoxib,etoricoxib,most,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",1,etoricoxib,Heart Damage,Withdraw
112,revlimid,lenalidomide,lenalidomide,most,Nc1cccc2c1C[NH+](C1CCC(=O)NC1=O)C2=O,"InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)/p+1",1,lenalidomide,Heart Damage,bw
113,byfavo,remimazolam besylate,remimazolam besylate,most,COC(=O)CCC1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,"InChI=1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3",1,remimazolam besylate,Mixed,bw
114,tasigna,nilotinib,nilotinib,most,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(N=c4nc(-c5cccnc5)cc[n-]4)c3)cc(C(F)(F)F)c2)cn1,"InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H2,33,35,36,37,39)/p-1",1,nilotinib,Arrhythmia,bw
115,cinacalcet,cinacalcet,cinacalcet hydrochloride,most,CC([NH2+]CCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/p+1",1,cinacalcet,Arrhythmia,wp
116,pomalyst,pomalidomide,pomalidomide,most,Nc1cccc2c1C(=O)[NH+](C1CCC(=O)NC1=O)C2=O,"InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)/p+1",1,pomalidomide,Heart Damage,bw
117,idarubicin hydrochloride,idarubicin hydrochloride,idarubicin hydrochloride,most,CC(=O)C1(O)C=C(OC2CC([NH3+])C(O)C(C)O2)c2c(c([O-])c3c([O-])c4ccccc4c([O-])c3c2[O-])C1,"InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,9-10,15,17,21,29-34H,7-8,27H2,1-2H3/p-3",1,idarubicin hydrochloride,Mixed,bw
118,pioglitazone,pioglitazone,pioglitazone,most,CCc1ccc(CCOc2ccc(Cc3sc(=O)[n-]c3[O-])cc2)nc1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12H,2,9-11H2,1H3,(H2,21,22,23)/p-2",1,pioglitazone,Heart Damage,bw
119,precedex,dexmedetomidine hydrochloride,dexmedetomidine hydrochloride,most,Cc1cccc(C(C)c2c[n-]cn2)c1C,"InChI=1S/C13H15N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3/q-1",1,dexmedetomidine hydrochloride,Mixed,wp
120,dehydrated alcohol,alcohol,alcohol,most,CCO,"InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3",1,alcohol,Mixed,wp
121,cabergoline,cabergoline,cabergoline,most,C=CC[NH+]1CC(C(=O)[NH+](CCC[NH+](C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,"InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/p+3",1,cabergoline,Heart Damage,wp
122,,tegaserod,tegaserod,most,CCCCC[NH+]=C(N)NN=Cc1c[nH]c2ccc(OC)cc12,"InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/p+1",1,tegaserod,,sp
123,asclera,polidocanol,polidocanol,most,CCCCCCCCCCCCOCCO,"InChI=1S/C14H30O2/c1-2-3-4-5-6-7-8-9-10-11-13-16-14-12-15/h15H,2-14H2,1H3",1,polidocanol,Heart Damage,wp
124,erythrocin stearate,erythromycin stearate,erythromycin stearate,most,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O,"InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/p+1",1,erythromycin stearate,Arrhythmia,wp
125,invega hafyera,paliperidone palmitate,paliperidone palmitate,most,CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CC[NH+]1CCC(c3noc4cc(F)ccc34)CC1)c2=O,"InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3/p+1",1,paliperidone palmitate,Arrhythmia,wp
126,mavenclad,cladribine,cladribine,most,N=c1[n-]c(Cl)nc2c1ncn2C1CC(O)C(CO)O1,"InChI=1S/C10H11ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H-,12,14,15)/q-1",1,cladribine,Heart Damage,wp
127,permax,pergolide,pergolide,most,CCC[NH+]1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,"InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/p+1",1,pergolide,Heart Damage,bw
128,imbruvica,ibrutinib,ibrutinib,most,C=CC(=O)[NH+]1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(=N)[n-]cnc32)C1,"InChI=1S/C25H23N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H-,26,27,28,29)/q-1/p+1",1,ibrutinib,Mixed,wp
129,aveed,testosterone undecanoate,testosterone undecanoate,most,CCCCCCCCCCC(=O)OC1CCC2C3CC=C4CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h13,24-27H,4-12,14-21H2,1-3H3",1,testosterone undecanoate,Heart Damage,wp
130,fluphenazine decanoate,fluphenazine decanoate,fluphenazine decanoate,most,CCCCCCCCCC(=O)OCC[NH+]1CC[NH+](CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,"InChI=1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3/p+2",1,fluphenazine decanoate,Heart Damage,bw
131,haloperidol decanoate,haloperidol decanoate,haloperidol decanoate,most,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CC[NH+](CCCC(=O)c2ccc(F)cc2)CC1,"InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3/p+1",1,haloperidol decanoate,Mixed,bw
132,propafenone,propafenone hydrochloride,propafenone,most,CCC[NH2+]CC(O)COc1ccccc1C(=O)CCc1ccccc1,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3/p+1",1,propafenone hydrochloride,Mixed,wp
133,cerdelga,eliglustat,eliglustat,most,CCCCCCCC(=O)NC(C[NH+]1CCCC1)C(O)c1ccc2c(c1)OCCO2,"InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/p+1",1,eliglustat,Arrhythmia,wp
134,adenosine,adenosine,adenosine,most,N=c1[n-]cnc2c1ncn2C1OC(CO)C(O)C1O,"InChI=1S/C10H12N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H-,11,12,13)/q-1",1,adenosine,Arrhythmia,wp
135,zelboraf,vemurafenib,vemurafenib,most,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,"InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)",1,vemurafenib,Arrhythmia,wp
136,brilinta,ticagrelor,ticagrelor,most,CCCSc1nc(=NC2CC2c2ccc(F)c(F)c2)c2nnn(C3CC(OCCO)C(O)C3O)c2[n-]1,"InChI=1S/C23H27F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3/q-1",1,ticagrelor,Arrhythmia,wp
137,chloroquine phosphate,chloroquine phosphate,chloroquine phosphate,most,CC[NH+](CC)CCCC(C)N=c1cc[n-]c2cc(Cl)ccc12,"InChI=1S/C18H25ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3/q-1/p+1",1,chloroquine phosphate,Mixed,wp
138,,dexfenfluramine,dexfenfluramine,most,CC[NH2+]C(C)Cc1cccc(C(F)(F)F)c1,"InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/p+1",1,dexfenfluramine,Heart Damage,Withdraw
139,qinlock,ripretinib,ripretinib,most,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2c[n-]c(=NC)cc21,"InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H3,27,28,29,30,32,33)/p-1",1,ripretinib,Heart Damage,wp
140,vardenafil hydrochloride,vardenafil hydrochloride,vardenafil,most,CCCc1nc(C)c2c(=O)[n-]c(-c3cc(S(=O)(=O)[NH+]4CC[NH+](CC)CC4)ccc3OCC)nn12,"InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)/p+1",1,vardenafil hydrochloride,Arrhythmia,wp
141,barhemsys,amisulpride,amisulpride,most,CC[NH+]1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,"InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/p+1",1,amisulpride,Arrhythmia,wp
142,sprycel,dasatinib,dasatinib,most,Cc1nc(=Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)[n-]1,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H2,24,25,26,27,28,32)",1,dasatinib,Mixed,wp
143,trovan,trovafloxacin mesylate,trovafloxacin mesylate,most,[NH3+]C1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)[O-])cn4-c3ccc(F)cc3F)CC12,"InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)",1,trovafloxacin mesylate,Heart Damage,wp
144,,lidoflazine,lidoflazine,most,Cc1cccc(C)c1NC(=O)C[NH+]1CC[NH+](CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,"InChI=1S/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36)/p+2",1,lidoflazine,Arrhythmia,Withdraw
145,lupkynis,voclosporin,voclosporin,most,C=CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)[NH+](C)CC(=O)[NH+](C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)[NH+](C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)[NH+](C)C(CC(C)C)C(=O)[NH+](C)C(CC(C)C)C(=O)[NH+](C)C(C(C)C)C(=O)[NH+]1C,"InChI=1S/C63H111N11O12/c1-25-27-28-29-41(15)53(76)52-57(80)66-44(26-2)59(82)68(18)34-49(75)69(19)45(30-35(3)4)56(79)67-50(39(11)12)62(85)70(20)46(31-36(5)6)55(78)64-42(16)54(77)65-43(17)58(81)71(21)47(32-37(7)8)60(83)72(22)48(33-38(9)10)61(84)73(23)51(40(13)14)63(86)74(52)24/h25,27-28,35-48,50-53,76H,1,26,29-34H2,2-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/p+7",1,voclosporin,Mixed,wp
146,noxafil,posaconazole,posaconazole; posaconazole,most,CCC(C(C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,"InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3",1,posaconazole,Arrhythmia,wp
147,haloperidol,haloperidol lactate,haloperidol lactate,most,O=C(CCC[NH+]1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2/p+1",1,haloperidol lactate,Mixed,bw
148,farydak,panobinostat,panobinostat lactate,most,Cc1[nH]c2ccccc2c1CC[NH2+]Cc1ccc(C=CC(O)=NO)cc1,"InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/p+1",1,panobinostat,Mixed,bw
149,milrinone lactate,milrinone lactate,milrinone lactate,most,Cc1[n-]c(=O)c(C#N)cc1-c1ccncc1,"InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,14,15,16)/p-1",1,milrinone lactate,Arrhythmia,wp
150,flecainide acetate,flecainide acetate,flecainide acetate,most,O=C(NCC1CCCC[NH2+]1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,"InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)/p+1",1,flecainide acetate,Mixed,bw
151,vantas,histrelin acetate,histrelin acetate,most,CCNC(=O)C1CCC[NH+]1C(=O)C(CCCNC(N)=[NH2+])NC(=O)C(CC(C)C)NC(=O)C(Cc1cn(Cc2ccccc2)cn1)NC(=O)C(Cc1ccc([O-])cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1cnc[n-]1)NC(=O)C1CCC(=O)N1,"InChI=1S/C66H86N18O12/c1-4-70-64(95)55-17-11-25-84(55)65(96)48(16-10-24-71-66(67)68)76-58(89)49(26-38(2)3)77-62(93)53(30-43-34-83(37-74-43)33-40-12-6-5-7-13-40)81-59(90)50(27-39-18-20-44(86)21-19-39)78-63(94)54(35-85)82-60(91)51(28-41-31-72-46-15-9-8-14-45(41)46)79-61(92)52(29-42-32-69-36-73-42)80-57(88)47-22-23-56(87)75-47/h5-9,12-15,18-21,31-32,34,36-38,47-55,72,85H,4,10-11,16-17,22-30,33,35H2,1-3H3,(H15,67,68,69,70,71,73,75,76,77,78,79,80,81,82,86,87,88,89,90,91,92,93,94,95)",1,histrelin acetate,Mixed,wp
152,gilenya,fingolimod hcl,fingolimod hydrochloride,most,CCCCCCCCc1ccc(CCC([NH3+])(CO)CO)cc1,"InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3/p+1",1,fingolimod hcl,Mixed,wp
153,dyanavel xr; dyanavel xr,amphetamine,amphetamine,most,CC([NH3+])Cc1ccccc1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/p+1",1,amphetamine,Mixed,wp
154,xcopri; xcopri maintenance pack; xcopri titration pack,cenobamate,cenobamate,most,NC(=O)OC(Cn1ncnn1)c1ccccc1Cl,"InChI=1S/C10H10ClN5O2/c11-8-4-2-1-3-7(8)9(18-10(12)17)5-16-14-6-13-15-16/h1-4,6,9H,5H2,(H2,12,17)",1,cenobamate,Arrhythmia,wp
155,ropinirole hydrochloride,ropinirole hydrochloride,ropinirole hydrochloride,most,CCC[NH+](CCC)CCc1cccc2[n-]c([O-])cc12,"InChI=1S/C16H23N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7,12,19H,3-4,8-11H2,1-2H3/q-1",1,ropinirole hydrochloride,Heart Damage,wp
156,,clobutinol,clobutinol,most,CC(C[NH+](C)C)C(C)(O)Cc1ccc(Cl)cc1,"InChI=1S/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-12-5-7-13(15)8-6-12/h5-8,11,17H,9-10H2,1-4H3/p+1",1,clobutinol,Arrhythmia,Withdraw
157,labetalol hydrochloride,labetalol hydrochloride,labetalol,most,CC(CCc1ccccc1)[NH2+]CC(O)c1ccc([O-])c(C(N)=O)c1,"InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)",1,labetalol hydrochloride,Heart Damage,wp
158,,prenylamine,prenylamine,most,CC(Cc1ccccc1)[NH2+]CCC(c1ccccc1)c1ccccc1,"InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3/p+1",1,prenylamine,Arrhythmia,Withdraw
159,,benfluorex,benfluorex,most,CC(Cc1cccc(C(F)(F)F)c1)[NH2+]CCOC(=O)c1ccccc1,"InChI=1S/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16/h2-9,13-14,23H,10-12H2,1H3/p+1",1,benfluorex,Heart Damage,Withdraw
160,,terodiline,terodiline,most,CC(CC(c1ccccc1)c1ccccc1)[NH2+]C(C)(C)C,"InChI=1S/C20H27N/c1-16(21-20(2,3)4)15-19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,16,19,21H,15H2,1-4H3/p+1",1,terodiline,Arrhythmia,Withdraw
161,zykadia,ceritinib,ceritinib,most,Cc1cc(N=c2[n-]cc(Cl)c(=Nc3ccccc3S(=O)(=O)C(C)C)[n-]2)c(OC(C)C)cc1C1CC[NH2+]CC1,"InChI=1S/C28H34ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3/q-2/p+1",1,ceritinib,Arrhythmia,wp
162,atenolol,atenolol,atenolol,most,CC(C)[NH2+]CC(O)COc1ccc(CC(N)=O)cc1,"InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)/p+1",1,atenolol,Heart Damage,wp
163,nexplanon,etonogestrel,etonogestrel,most,C#CC1(O)CCC2C3CC=C4CC(=O)CCC4C3C(=C)CC21CC,"InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,6,17-20,24H,3-4,7-13H2,1H3",1,etonogestrel,Heart Damage,wp
164,methadone hydrochloride,methadone hydrochloride,methadone hydrochloride,most,CCC(=O)C(CC(C)[NH+](C)C)(c1ccccc1)c1ccccc1,"InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3/p+1",1,methadone hydrochloride,Mixed,bw
165,midazolam,midazolam hydrochloride,midazolam hydrochloride,most,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",1,midazolam hydrochloride,Arrhythmia,wp
166,ingrezza,valbenazine,valbenazine tosylate,most,COc1cc2c(cc1OC)C1CC(OC(=O)C([NH3+])C(C)C)C(CC(C)C)C[NH+]1CC2,"InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/p+2",1,valbenazine,Arrhythmia,wp
167,inrebic,fedratinib hydrochloride,fedratinib hydrochloride,most,Cc1c[n-]c(=Nc2ccc(OCC[NH+]3CCCC3)cc2)[n-]c1=Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,"InChI=1S/C27H34N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3/q-2/p+1",1,fedratinib hydrochloride,Heart Damage,wp
168,phentolamine mesylate,phentolamine mesylate,phentolamine mesylate,most,Cc1ccc(N(CC2=[NH+]CCN2)c2cccc([O-])c2)cc1,"InChI=1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19)",1,phentolamine mesylate,Mixed,wp
169,celecoxib,celecoxib,celecoxib,most,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",1,celecoxib,Heart Damage,bw
170,ciprofloxacin,ciprofloxacin,ciprofloxacin hydrochloride,most,O=C([O-])c1cn(C2CC2)c2cc(N3CC[NH2+]CC3)c(F)cc2c1=O,"InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",1,ciprofloxacin,Arrhythmia,wp
171,stivarga,regorafenib,regorafenib monohydrate,most,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",1,regorafenib,Heart Damage,wp
172,ketorolac tromethamine,ketorolac tromethamine,ketorolac tromethamine,most,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)[O-],"InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)/p-1",1,ketorolac tromethamine,Heart Damage,bw
173,bosulif,bosutinib monohydrate,bosutinib monohydrate,most,COc1cc(N=c2c(C#N)c[n-]c3cc(OCCC[NH+]4CC[NH+](C)CC4)c(OC)cc23)c(Cl)cc1Cl,"InChI=1S/C26H28Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3/q-1/p+2",1,bosutinib monohydrate,Heart Damage,wp
174,,orciprenaline,orciprenaline,most,CC(C)[NH2+]CC(O)c1cc([O-])cc([O-])c1,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3/p-1",1,orciprenaline,Arrhythmia,Withdraw
175,propranolol hydrochloride,propranolol hydrochloride,propranolol hydrochloride,most,CC(C)[NH2+]CC(O)COc1cccc2ccccc12,"InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3/p+1",1,propranolol hydrochloride,Mixed,wp
176,sulindac,sulindac,sulindac,most,CC1=C(CC(=O)[O-])c2cc(F)ccc2C1=Cc1ccc([S+](C)O)cc1,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10,24H,11H2,1-2H3",1,sulindac,Heart Damage,bw
177,mefenamic acid,mefenamic acid,mefenamic acid,most,Cc1cccc(Nc2ccccc2C(=O)[O-])c1C,"InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)/p-1",1,mefenamic acid,Heart Damage,bw
178,nalfon,fenoprofen calcium,fenoprofen calcium,most,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1,"InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)/p-1",1,fenoprofen calcium,Heart Damage,bw
179,succinylcholine chloride,succinylcholine chloride,succinylcholine chloride dihydrate,most,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,"InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2",1,succinylcholine chloride,Arrhythmia,bw
180,mexiletine hydrochloride,mexiletine hydrochloride,mexiletine hydrochloride,most,Cc1cccc(C)c1OCC(C)[NH3+],"InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3/p+1",1,mexiletine hydrochloride,Arrhythmia,bw
181,lucemyra,lofexidine hydrochloride,lofexidine hydrochloride,most,CC(Oc1c(Cl)cccc1Cl)C1=[NH+]CCN1,"InChI=1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15)/p+1",1,lofexidine hydrochloride,Mixed,wp
182,clarithromycin,clarithromycin,clarithromycin,most,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,"InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/p+1",1,clarithromycin,Arrhythmia,wp
183,,levomethadyl acetate,levomethadyl acetate,most,CCC(OC(C)=O)C(CC(C)[NH+](C)C)(c1ccccc1)c1ccccc1,"InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/p+1",1,levomethadyl acetate,Arrhythmia,Withdraw
184,paliperidone,paliperidone,paliperidone,most,Cc1nc2n(c(=O)c1CC[NH+]1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,"InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3/p+1",1,paliperidone,Arrhythmia,wp
185,ifosfamide,ifosfamide,ifosfamide,most,O=P1([NH2+]CCCl)OCCC[NH+]1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)/p+2",1,ifosfamide,Mixed,wp
186,esmolol hydrochloride,esmolol hydrochloride,esmolol hydrochloride,most,COC(=O)CCc1ccc(OCC(O)C[NH2+]C(C)C)cc1,"InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3/p+1",1,esmolol hydrochloride,Mixed,wp
187,multaq,dronedarone,dronedarone,most,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCC[NH+](CCCC)CCCC)cc1,"InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3/p+1",1,dronedarone,Mixed,bw
188,ixempra,ixabepilone,ixabepilone,most,CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)N1,"InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)",1,ixabepilone,Mixed,wp
189,factive,gemifloxacin mesylate,gemifloxacin mesylate,most,CON=C1CN(c2nc3c(cc2F)c(=O)c(C(=O)[O-])cn3C2CC2)CC1C[NH3+],"InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)",1,gemifloxacin mesylate,Arrhythmia,wp
190,definity rt,perflutren,perflutren,most,FC(F)(F)C(F)(F)C(F)(F)F,"InChI=1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11",1,perflutren,Mixed,bw
191,tibsovo,ivosidenib,ivosidenib,most,N#Cc1ccnc([NH+]2C(=O)CCC2C(=O)[NH+](c2cncc(F)c2)C(C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,"InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/p+2",1,ivosidenib,Arrhythmia,wp
192,diclofenac potassium,diclofenac potassium,diclofenac potassium,most,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)/p-1",1,diclofenac potassium,Heart Damage,bw
193,potassium acetate,potassium acetate,potassium acetate,most,CC(=O)[O-],"InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1",1,potassium acetate,Arrhythmia,wp
194,tagrisso,osimertinib,osimertinib,most,C=CC(=O)Nc1cc(N=c2nc(-c3cn(C)c4ccccc34)cc[n-]2)c(OC)cc1N(C)CC[NH+](C)C,"InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H2,29,30,31,32,36)",1,osimertinib,Mixed,wp
195,lithium,lithium,lithium citrate,most,O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-],"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3",1,lithium,Mixed,wp
196,mirtazapine,mirtazapine,mirtazapine,most,C[NH+]1CC[NH+]2c3ncccc3Cc3ccccc3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3/p+2",1,mirtazapine,Arrhythmia,wp
197,,astemizole,astemizole,most,COc1ccc(CC[NH+]2CCC(N=c3[n-]c4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,"InChI=1S/C28H30FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3/q-1/p+1",1,astemizole,Arrhythmia,Withdraw
198,tetrabenazine,tetrabenazine,tetrabenazine,most,COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)C[NH+]1CC2,"InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/p+1",1,tetrabenazine,Mixed,wp
199,invirase,saquinavir mesylate,saquinavir mesylate,most,CC(C)(C)NC(=O)C1CC2CCCCC2C[NH+]1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/p+1",1,saquinavir mesylate,Mixed,wp
200,droperidol,droperidol,droperidol,most,O=C(CCC[NH+]1CC=C(n2c(=O)[n-]c3ccccc32)CC1)c1ccc(F)cc1,"InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)",1,droperidol,Arrhythmia,bw
201,rozlytrek,entrectinib,entrectinib,most,C[NH+]1CCN(c2ccc(C(=O)N=c3[n-][n-]c4ccc(Cc5cc(F)cc(F)c5)cc34)c([NH2+]C3CCOCC3)c2)CC1,"InChI=1S/C31H32F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24H,6-14H2,1H3,(H-2,34,35,36,37,40)/q-2/p+2",1,entrectinib,Mixed,wp
202,fluconazole,fluconazole,fluconazole,most,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,"InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",1,fluconazole,Arrhythmia,wp
203,almotriptan,almotriptan,almotriptan malate,most,C[NH+](C)CCc1c[nH]c2ccc(CS(=O)(=O)[NH+]3CCCC3)cc12,"InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3/p+2",1,almotriptan,Mixed,wp
204,efavirenz,efavirenz,efavirenz,most,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,"InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)",1,efavirenz,Arrhythmia,wp
205,,cisapride,cisapride,most,COc1cc(N)c(Cl)cc1C(=O)NC1CC[NH+](CCCOc2ccc(F)cc2)CC1OC,"InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/p+1",1,cisapride,Arrhythmia,Withdraw
206,tafinlar,dabrafenib,dabrafenib mesylate,most,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2cc[n-]c(=N)n2)s1,"InChI=1S/C23H19F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H-,27,28,29)/q-1",1,dabrafenib,Heart Damage,wp
207,daypro,oxaprozin,oxaprozin,most,O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,"InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)/p-1",1,oxaprozin,Heart Damage,bw
208,exkivity,mobocertinib,mobocertinib,most,C=CC(=O)Nc1cc(N=c2nc(-c3cn(C)c4ccccc34)c(C(=O)OC(C)C)c[n-]2)c(OC)cc1N(C)CC[NH+](C)C,"InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H2,33,34,35,36,40,41)",1,mobocertinib,Mixed,bw
209,vyvanse,lisdexamfetamine dimesylate,lisdexamfetamine dimesylate,most,CC(Cc1ccccc1)NC(=O)C([NH3+])CCCC[NH3+],"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/p+2",1,lisdexamfetamine dimesylate,Mixed,wp
210,foscavir,foscarnet sodium,foscarnet sodium,most,O=C([O-])[P](=O)(=O)O,"InChI=1S/CH2O5P/c2-1(3)7(4,5)6/h(H,2,3)(H,4,5,6)/p-1",1,foscarnet sodium,Arrhythmia,wp
211,olinvyk,oliceridine,oliceridine,most,COc1ccsc1C[NH2+]CCC1(c2ccccn2)CCOC2(CCCC2)C1,"InChI=1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/p+1",1,oliceridine,Mixed,wp
212,technetium tc 99m sestamibi,technetium tc 99m sestamibi,tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate,most,[C-]#[N+]CC(C)(C)OC,"InChI=1S/C6H11NO/c1-6(2,8-4)5-7-3/h5H2,1-2,4H3",1,technetium tc 99m sestamibi,Mixed,wp
213,clozapine,clozapine,clozapine,most,C[NH+]1CCN(C2=[NH+]c3cc(Cl)ccc3Nc3ccccc32)CC1,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3/p+2",1,clozapine,Mixed,bw
214,erleada,apalutamide,apalutamide,most,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,"InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)",1,apalutamide,Heart Damage,wp
215,daurismo,glasdegib,glasdegib,most,C[NH+]1CCC(NC(=O)Nc2ccc(C#N)cc2)CC1c1nc2ccccc2[n-]1,"InChI=1S/C21H22N6O/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H3,23,24,25,26,28)",1,glasdegib,Arrhythmia,wp
216,carvedilol,carvedilol,carvedilol,most,COc1ccccc1OCC[NH2+]CC(O)COc1cccc2[nH]c3ccccc3c12,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3/p+1",1,carvedilol,Mixed,wp
217,tacrolimus,tacrolimus; tacrolimus capsules,tacrolimus,most,C=CCC1=CC(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)[NH+]3CCCCC3C(=O)OC(C(C)=CC3CCC(O)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC,"InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,25-26,28-30,32-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/p+1",1,tacrolimus; tacrolimus capsules,Mixed,wp
218,imatinib mesylate,imatinib mesylate,imatinib mesylate,most,Cc1ccc(NC(=O)c2ccc(C[NH+]3CC[NH+](C)CC3)cc2)cc1N=c1nc(-c2cccnc2)cc[n-]1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H2,31,32,33,34,37)/p+1",1,imatinib mesylate,Heart Damage,wp
219,fanapt,iloperidone,iloperidone,most,COc1cc(C(C)=O)ccc1OCCC[NH+]1CCC(c2noc3cc(F)ccc23)CC1,"InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3/p+1",1,iloperidone,Mixed,wp
220,ketek,telithromycin,telithromycin,most,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C2[NH+](CCCCn3cnc(-c4cccnc4)c3)C(=O)OC12C,"InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/p+2",1,telithromycin,Arrhythmia,wp
221,ranolazine,ranolazine,ranolazine,most,COc1ccccc1OCC(O)C[NH+]1CC[NH+](CC(=O)Nc2c(C)cccc2C)CC1,"InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)/p+2",1,ranolazine,Arrhythmia,wp
222,pradaxa,dabigatran etexilate mesylate,dabigatran etexilate mesylate,most,CCCCCCOC(=O)[NH+]=C(N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,"InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)/p+1",1,dabigatran etexilate mesylate,Heart Damage,wp
223,bromocriptine mesylate,bromocriptine mesylate,bromocriptine mesylate,most,CC(C)CC1C(=O)[NH+]2CCCC2C2(O)OC(NC(=O)C3=CC4c5cccc6[nH]c(Br)c(c56)CC4[NH+](C)C3)(C(C)C)C(=O)[NH+]12,"InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-17,20,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/p+3",1,bromocriptine mesylate,Heart Damage,wp
224,rinvoq,upadacitinib,upadacitinib,most,CCC1C[NH+](C(=O)NCC(F)(F)F)CC1c1cnc2cnc3[nH]ccc3n12,"InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/p+1",1,upadacitinib,Heart Damage,bw
225,tavalisse,fostamatinib,fostamatinib,most,COc1cc(N=c2nc(N=c3ccc4c([n-]3)N(CO[P](=O)(=O)O)C(=O)C(C)(C)O4)c(F)c[n-]2)cc(OC)c1OC,"InChI=1S/C23H23FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H-2,25,26,27,28,29,32,33,34)/q-2",1,fostamatinib,Heart Damage,wp
226,signifor lar,pasireotide,pasireotide,most,[NH3+]CCCCC1NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(c2ccccc2)NC(=O)C2CC(OC(=O)NCC[NH3+])C[NH+]2C(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(OCc3ccccc3)cc2)NC1=O,"InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/p+3",1,pasireotide,Arrhythmia,wp
227,dipyridamole,dipyridamole,dipyridamole,most,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,"InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2",1,dipyridamole,Mixed,wp
228,conray,iothalamate meglumine,iothalamate meglumine,most,C[NH2+]CC(O)C(O)C(O)C(O)CO,"InChI=1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/p+1",1,iothalamate meglumine,Mixed,wp
229,,buflomedil,buflomedil,most,COc1cc(OC)c(C(=O)CCC[NH+]2CCCC2)c(OC)c1,"InChI=1S/C17H25NO4/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18/h11-12H,4-10H2,1-3H3/p+1",1,buflomedil,Arrhythmia,Withdraw
230,cotellic,cobimetinib,cobimetinib fumarate,most,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)[NH+]1CC(O)(C2CCCC[NH2+]2)C1,"InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/p+2",1,cobimetinib,Heart Damage,wp
231,xtandi,enzalutamide,enzalutamide,most,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,"InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)",1,enzalutamide,Heart Damage,wp
232,multihance,gadobenate dimeglumine,gadobenate dimeglumine,most,O=C([O-])C[NH+](CC[NH+](CC(=O)[O-])CC(=O)[O-])CC[NH+](CC(=O)[O-])C(COCc1ccccc1)C(=O)[O-],"InChI=1S/C22H31N3O11/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35)/p-2",1,gadobenate dimeglumine,Arrhythmia,wp
233,inlyta,axitinib,axitinib,most,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)[n-]nc2c1,"InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H2,23,24,25,26,27)/p-1",1,axitinib,Heart Damage,wp
234,nexavar,sorafenib,sorafenib,most,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",1,sorafenib,Mixed,wp
235,lexiscan(r) (regadenoson),lexiscan(r) (regadenoson),regadenoson,most,CNC(=O)c1cnn(-c2nc(=N)c3ncn(C4OC(CO)C(O)C4O)c3[n-]2)c1,"InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H3,16,17,20,21,27)/p-1",1,lexiscan(r) (regadenoson),Mixed,wp
236,sumatriptan succinate,sumatriptan succinate,sumatriptan succinate,most,CNS(=O)(=O)Cc1ccc2[nH]cc(CC[NH+](C)C)c2c1,"InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3/p+1",1,sumatriptan succinate,Mixed,wp
237,fotivda,tivozanib,tivozanib hydrochloride,most,COc1cc2nccc(Oc3ccc(NC(=O)N=c4cc(C)o[n-]4)c(Cl)c3)c2cc1OC,"InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)/p-1",1,tivozanib,Heart Damage,wp
238,osphena,ospemifene,ospemifene,most,OCCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1,"InChI=1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2",1,ospemifene,Heart Damage,wp
239,tradjenta,linagliptin,linagliptin,most,CC#CCn1c(N2CCCC([NH3+])C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,"InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/p+1",1,linagliptin,Heart Damage,wp
240,,encainide,encainide,most,COc1ccc(C(=O)Nc2ccccc2CCC2CCCC[NH+]2C)cc1,"InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)/p+1",1,encainide,Arrhythmia,Withdraw
241,idhifa,enasidenib mesylate,enasidenib mesylate,most,CC(C)(O)CN=c1[n-]c(-c2cccc(C(F)(F)F)n2)nc(=Nc2ccnc(C(F)(F)F)c2)[n-]1,"InChI=1S/C19H15F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3/q-2",1,enasidenib mesylate,Heart Damage,wp
242,sirturo,bedaquiline fumarate,bedaquiline fumarate,most,COc1nc2ccc(Br)cc2cc1C(c1ccccc1)C(O)(CC[NH+](C)C)c1cccc2ccccc12,"InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/p+1",1,bedaquiline fumarate,Arrhythmia,bw
243,fosphenytoin,fosphenytoin sodium,fosphenytoin sodium,most,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)[NH+]1CO[P](=O)(=O)O,"InChI=1S/C16H14N2O6P/c19-14-16(12-7-3-1-4-8-12,13-9-5-2-6-10-13)17-15(20)18(14)11-24-25(21,22)23/h1-10H,11H2,(H,17,20)(H,21,22,23)/p+1",1,fosphenytoin sodium,Mixed,bw
244,emcyt,estramustine phosphate sodium,estramustine phosphate sodium,most,CC12CCC3c4ccc(OC(=O)[NH+](CCCl)CCCl)cc4CCC3C1CCC2O[P](=O)(=O)O,"InChI=1S/C23H31Cl2NO6P/c1-23-9-8-18-17-5-3-16(31-22(27)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)32-33(28,29)30/h3,5,14,18-21H,2,4,6-13H2,1H3,(H,28,29,30)/p+1",1,estramustine phosphate sodium,Heart Damage,wp
245,meloxicam,meloxicam,meloxicam,most,Cc1c[n-]c(=NC(=O)C2C(=O)c3ccccc3S(=O)(=O)[NH+]2C)s1,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,11H,1-2H3,(H,15,16,19)",1,meloxicam,Heart Damage,bw
246,,sertindole,sertindole,most,O=C1NCC[NH+]1CC[NH+]1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,"InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)/p+2",1,sertindole,Arrhythmia,Withdraw
247,northera,droxidopa,droxidopa,most,[NH3+]C(C(=O)[O-])C(O)c1ccc([O-])c([O-])c1,"InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/p-2",1,droxidopa,Heart Damage,bw
248,plaquenil,hydroxychloroquine sulfate,hydroxychloroquine sulfate,most,CC[NH+](CCO)CCCC(C)N=c1cc[n-]c2cc(Cl)ccc12,"InChI=1S/C18H25ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3/q-1/p+1",1,hydroxychloroquine sulfate,Mixed,wp
249,sotradecol,tetradecyl hydrogen sulfate (ester),tetradecyl hydrogen sulfate (ester),most,CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-],"InChI=1S/C14H30O4S/c1-5-7-8-13(6-2)9-10-14(11-12(3)4)18-19(15,16)17/h12-14H,5-11H2,1-4H3,(H,15,16,17)/p-1",1,tetradecyl hydrogen sulfate (ester),Heart Damage,wp
250,lenvima,lenvatinib,lenvatinib,most,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,"InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)",1,lenvatinib,Mixed,wp
251,dofetilide,dofetilide,dofetilide,most,C[NH+](CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,"InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3/p+1",1,dofetilide,Arrhythmia,bw
252,sodium tetradecyl sulfate,sodium tetradecyl sulfate,sodium tetradecyl sulfate,most,CCCCCCCCCCCCCCOS(=O)(=O)[O-],"InChI=1S/C14H30O4S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17/h2-14H2,1H3,(H,15,16,17)/p-1",1,sodium tetradecyl sulfate,Heart Damage,wp
253,xyosted,testosterone enanthate,testosterone enanthate,most,CCCCCCC(=O)OC1CCC2C3CC=C4CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h9,20-23H,4-8,10-17H2,1-3H3",1,testosterone enanthate,Heart Damage,bw
254,retevmo,selpercatinib,selpercatinib,most,COc1ccc(C[NH+]2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,"InChI=1S/C29H31N7O3/c1-29(2,37)18-39-24-9-25(28-21(10-30)13-33-36(28)17-24)20-5-6-26(31-12-20)34-15-22-8-23(16-34)35(22)14-19-4-7-27(38-3)32-11-19/h4-7,9,11-13,17,22-23,37H,8,14-16,18H2,1-3H3/p+1",1,selpercatinib,Mixed,wp
255,tolmetin sodium,tolmetin sodium,tolmetin sodium,most,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1,"InChI=1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18)/p-1",1,tolmetin sodium,Heart Damage,bw
256,,mibefradil,mibefradil,most,COCC(=O)OC1(CC[NH+](C)CCCc2nc3ccccc3[n-]2)CCc2cc(F)ccc2C1C(C)C,"InChI=1S/C29H37FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3/q-1/p+1",1,mibefradil,Arrhythmia,Withdraw
257,estradiol valerate,estradiol valerate,estradiol valerate,most,CCCCC(=O)OC1CCC2C3CCc4cc([O-])ccc4C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/p-1",1,estradiol valerate,Heart Damage,bw
258,metoprolol succinate,metoprolol succinate,metoprolol tartrate,most,COCCc1ccc(OCC(O)C[NH2+]C(C)C)cc1,"InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3/p+1",1,metoprolol succinate,Heart Damage,bw
259,vimpat,lacosamide,lacosamide,most,COCC(NC(C)=O)C(=O)NCc1ccccc1,"InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)",1,lacosamide,Arrhythmia,wp
260,testosterone cypionate,testosterone cypionate,testosterone cypionate,most,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3",1,testosterone cypionate,NA,NA
261,estradiol,estradiol,estradiol,most,CC12CCC3c4ccc([O-])cc4CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/p-1",1,estradiol,Heart Damage,bw
262,toremifene citrate,toremifene citrate,toremifene citrate,most,C[NH+](C)CCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1,"InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/p+1",1,toremifene citrate,Arrhythmia,bw
263,januvia,sitagliptin,sitagliptin phosphate,most,[NH3+]C(CC(=O)[NH+]1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,"InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/p+2",1,sitagliptin,Heart Damage,wp
264,,rofecoxib,rofecoxib,most,CS(=O)(=O)c1ccc(-c2coc([O-])c2-c2ccccc2)cc1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-11,18H,1H3/p-1",1,rofecoxib,Heart Damage,Withdraw
265,progesterone,progesterone,progesterone,most,CC(=O)C1CCC2C3CC=C4CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,16-19H,5-12H2,1-3H3",1,progesterone,Heart Damage,bw
266,zolmitriptan,zolmitriptan,zolmitriptan,most,C[NH+](C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,"InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/p+1",1,zolmitriptan,Mixed,wp
267,atazanavir,atazanavir,atazanavir sulfate,most,COC(=O)NC(C(=O)[N-]N(Cc1ccc(-c2ccccn2)cc1)CC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,"InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H4,40,41,42,43,46,47,48,49)/p-1",1,atazanavir,Arrhythmia,wp
268,tykerb,lapatinib,lapatinib ditosylate,most,CS(=O)(=O)CC[NH2+]Cc1ccc(-c2ccc3[n-]cnc(=Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,"InChI=1S/C29H25ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3/q-1/p+1",1,lapatinib,Mixed,wp
269,orgovyx,relugolix,relugolix,most,CO[N-]C(=O)Nc1ccc(-c2sc3c(c2C[NH+](C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,"InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)",1,relugolix,Arrhythmia,wp
270,naproxen sodium,naproxen sodium,naproxen sodium,most,COc1ccc2cc(C(C)C(=O)[O-])ccc2c1,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/p-1",1,naproxen sodium,Heart Damage,bw
271,levothyroxine sodium,levothyroxine sodium anhydrous,levothyroxine sodium anhydrous,most,[NH3+]C(Cc1cc(I)c(Oc2cc(I)c([O-])c(I)c2)c(I)c1)C(=O)[O-],"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/p-1",1,levothyroxine sodium anhydrous,Mixed,wp
272,mekinist,trametinib,trametinib dimethyl sulfoxide,most,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,"InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)",1,trametinib,Heart Damage,wp
273,nabumetone,nabumetone,nabumetone,most,COc1ccc2cc(CCC(C)=O)ccc2c1,"InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3",1,nabumetone,Heart Damage,bw
274,jakafi,ruxolitinib,ruxolitinib,most,N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,"InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)",1,ruxolitinib,Heart Damage,wp
275,hypaque sodium,diatrizoate sodium,diatrizoate sodium,most,CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)[O-])c1I,"InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)/p-1",1,diatrizoate sodium,Mixed,wp
276,mektovi,binimetinib,binimetinib,most,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)[N-]OCCO)cc21,"InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,25H,4-5H2,1H3,(H2,22,23,26)/p-1",1,binimetinib,Heart Damage,wp
277,enlon,edrophonium chloride,edrophonium chloride,most,CC[N+](C)(C)c1cccc([O-])c1,"InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3",1,edrophonium chloride,Arrhythmia,wp
278,caffeine citrate,caffeine citrate,caffeine citrate,most,Cn1c(=O)c2c(ncn2C)n(C)c1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",1,caffeine citrate,Mixed,wp
279,egaten,triclabendazole,triclabendazole,most,CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[n-]1,"InChI=1S/C14H8Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3/q-1",1,triclabendazole,Arrhythmia,wp
280,fexinidazole,fexinidazole,fexinidazole,most,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,"InChI=1S/C12H13N3O3S/c1-14-11(13-7-12(14)15(16)17)8-18-9-3-5-10(19-2)6-4-9/h3-7H,8H2,1-2H3",1,fexinidazole,Arrhythmia,wp
281,terbutaline sulfate,terbutaline sulfate,terbutaline sulfate,most,CC(C)(C)[NH2+]CC(O)c1cc([O-])cc([O-])c1,"InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3/p-1",1,terbutaline sulfate,Mixed,bw
282,kisqali,ribociclib,ribociclib succinate,most,C[NH+](C)C(=O)c1cc2c[n-]c(=Nc3ccc(N4CC[NH2+]CC4)cn3)nc2n1C1CCCC1,"InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28,32)/p+1",1,ribociclib,Arrhythmia,wp
283,yondelis,trabectedin,trabectedin,most,COc1cc2c(cc1[O-])CC[NH2+]C21CSC2c3c(OC(C)=O)c(C)c4c(c3C(COC1=O)[NH+]1C(O)C3Cc5cc(C)c(OC)c([O-])c5C(C21)[NH+]3C)OCO4,"InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/p+1",1,trabectedin,Heart Damage,wp
284,frovatriptan succinate,frovatriptan succinate,frovatriptan succinate,most,C[NH2+]C1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/p+1",1,frovatriptan succinate,Mixed,wp
285,isturisa,osilodrostat,osilodrostat phosphate,most,N#Cc1ccc(C2CCc3cncn32)c(F)c1,"InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2",1,osilodrostat,Arrhythmia,wp
286,meclofenamate sodium,meclofenamate sodium,meclofenamate sodium,most,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl,"InChI=1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)/p-1",1,meclofenamate sodium,Heart Damage,bw
287,caprelsa,vandetanib,vandetanib,most,COc1cc2c(=Nc3ccc(Br)cc3F)[n-]cnc2cc1OCC1CC[NH+](C)CC1,"InChI=1S/C22H23BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3/q-1/p+1",1,vandetanib,Mixed,bw
288,calcium gluconate,calcium gluconate,calcium gluconate monohydrate,most,O=C(C(O)C(O)O)C(O)C(O)CO,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,5-9,11-13H,1H2",1,calcium gluconate,Arrhythmia,wp
289,piroxicam,piroxicam,piroxicam,most,C[NH+]1C(C(=O)N=c2cccc[n-]2)C(=O)c2ccccc2S1(=O)=O,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,13H,1H3,(H,16,17,20)",1,piroxicam,Heart Damage,bw
290,indomethacin,indomethacin,indomethacin,most,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)/p-1",1,indomethacin,Mixed,ar
291,disopyramide phosphate,disopyramide phosphate,disopyramide phosphate,most,CC(C)[NH+](CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,"InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)/p+1",1,disopyramide phosphate,Mixed,wp
292,koselugo,selumetinib,selumetinib,most,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)[N-]OCCO)cc21,"InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,25H,4-5H2,1H3,(H2,22,23,26)/p-1",1,selumetinib,Heart Damage,wp
293,lamivudine,lamivudine,lamivudine,no,N=c1ccn(C2CSC(CO)O2)c(=O)[n-]1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/p-1",0,lamivudine,,no
294,amikacin sulfate,amikacin sulfate,amikacin sulfate,no,[NH3+]CCC(=O)C(O)[NH2+]C1CC([NH3+])C(OC2OC(C[NH3+])C(O)C(O)C2O)C(O)C1OC1OC(CO)C(O)C([NH3+])C1O,"InChI=1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-7,9-22,27-28,30-36H,1-5,23-26H2/p+5",0,amikacin sulfate,,no
295,streptomycin,streptomycin,streptomycin sulfate,no,C[NH2+]C1C(OC2C(OC3C(O)C(O)C([NH+]=C(N)N)C(O)C3[NH+]=C(N)N)OC(C)C2(O)C=O)OC(CO)C(O)C1O,"InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/p+3",0,streptomycin,,no
296,emtricitabine,emtricitabine,emtricitabine,no,N=c1[n-]c(=O)n(C2CSC(CO)O2)cc1F,"InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/p-1",0,emtricitabine,,no
297,entecavir,entecavir,entecavir,no,C=C1C(CO)C(O)CC1n1cnc2c(=O)[n-]c(=N)[n-]c21,"InChI=1S/C12H14N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H2-,13,15,16,20)/q-1/p-1",0,entecavir,,no
298,tabloid,thioguanine,thioguanine,no,N=c1[n-]c(=S)c2[n-]cnc2[n-]1,"InChI=1S/C5H3N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H2-2,6,7,8,9,10,11)/q-2/p-1",0,thioguanine,,no
299,isoniazid,isoniazid,isoniazid,no,N[N-]C(=O)c1ccncc1,"InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,(H3,7,8,9,10)/p-1",0,isoniazid,,no
300,zontivity,vorapaxar,vorapaxar sulfate,no,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=Cc1ccc(-c2cccc(F)c2)cn1,"InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)",0,vorapaxar,,CLINICAL PHARMACOLOGY
301,cefixime,cefixime,cefixime,no,C=CC1=C(C(=O)[O-])[NH+]2C(=O)C(=NC(=O)C([NH2+]OCC(=O)[O-])c3csc(=N)[n-]3)C2SC1,"InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,9,14,20H,1,3-4H2,(H4,17,18,22,23,26,27)/p-1",0,cefixime,,no
302,promacta,eltrombopag olamine,eltrombopag olamine,no,Cc1ccc(-n2[n-]c(C)c(N=Nc3cccc(-c4cccc(C(=O)[O-])c4)c3[O-])c2=O)cc1C,"InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13H,1-3H3,(H3,26,27,28,30,31,32,33)/p-3",0,eltrombopag olamine,,CLINICAL PHARMACOLOGY
303,folic acid,folic acid,folic acid,no,N=c1[n-]c(=O)c2nc(CNc3ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc3)cnc2[n-]1,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12H,5-7H2,(H7,20,21,22,24,25,26,27,28,29,30,31,32)/p-4",0,folic acid,,no
304,khapzory,levoleucovorin,levoleucovorin disodium,no,N=c1[n-]c2c(c(=O)[n-]1)[NH+](C=O)C(CNc1ccc(C(=O)NC(CCC(=O)[O-])C(=O)[O-])cc1)CN2,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13H,5-8H2,(H8,21,22,23,24,25,26,29,30,31,32,33,34)/p-3",0,levoleucovorin,,no
305,dalfampridine,dalfampridine,dalfampridine,no,N=c1cc[n-]cc1,"InChI=1S/C5H5N2/c6-5-1-3-7-4-2-5/h1-4H,(H-,6,7)/q-1",0,dalfampridine,,CLINICAL PHARMACOLOGY
306,lynparza,olaparib,olaparib,no,O=C(c1cc(Cc2n[n-]c(=O)c3ccccc23)ccc1F)[NH+]1CC[NH+](C(=O)C2CC2)CC1,"InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)/p+1",0,olaparib,,no
307,cefadroxil,cefadroxil hemihydrate,cefadroxil hemihydrate,no,CC1=C(C(=O)[O-])[NH+]2C(=O)C(NC(=O)C([NH3+])c3ccc([O-])cc3)C2SC1,"InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)",0,cefadroxil hemihydrate,,no
308,pranactin-citric,urea c-13,urea c-13,no,NC(N)=O,"InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)",0,urea c-13,,no
309,sucralfate,sucralfate,sucralfate,no,O=S(=O)([O-])OCC1OC(OC2(COS(=O)(=O)[O-])OC(COS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C2OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],"InChI=1S/C12H22O35S8/c13-48(14,15)37-1-4-6(43-51(22,23)24)8(45-53(28,29)30)9(46-54(31,32)33)11(40-4)42-12(3-39-50(19,20)21)10(47-55(34,35)36)7(44-52(25,26)27)5(41-12)2-38-49(16,17)18/h4-11H,1-3H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)(H,25,26,27)(H,28,29,30)(H,31,32,33)(H,34,35,36)/p-8",0,sucralfate,NA,NA
310,neutrexin,trimetrexate glucuronate,trimetrexate glucuronate,no,COc1cc(NCc2ccc3[n-]c(=N)[n-]c(=N)c3c2C)cc(OC)c1OC,"InChI=1S/C19H21N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H2-2,20,21,23,24)/q-2",0,trimetrexate glucuronate,,no
311,fluorodopa f18,fluorodopa f18,fluorodopa f-18,no,[NH3+]C(Cc1cc([O-])c([O-])cc1F)C(=O)[O-],"InChI=1S/C9H10FNO4/c10-5-3-8(13)7(12)2-4(5)1-6(11)9(14)15/h2-3,6,12-13H,1,11H2,(H,14,15)/p-2",0,fluorodopa f18,,no
312,pylarify,piflufolastat f-18,piflufolastat f-18,no,O=C([O-])CCC(NC(=O)NC(CCCCNC(=O)c1ccc(F)nc1)C(=O)[O-])C(=O)[O-],"InChI=1S/C18H23FN4O8/c19-13-6-4-10(9-21-13)15(26)20-8-2-1-3-11(16(27)28)22-18(31)23-12(17(29)30)5-7-14(24)25/h4,6,9,11-12H,1-3,5,7-8H2,(H,20,26)(H,24,25)(H,27,28)(H,29,30)(H2,22,23,31)/p-3",0,piflufolastat f-18,,no
313,hydroxyurea,hydroxyurea,hydroxyurea,no,NC(O)=[NH+]O,"InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)/p+1",0,hydroxyurea,,no
314,ezetimibe,ezetimibe,ezetimibe,no,O=C1C(CCC(O)c2ccc(F)cc2)C(c2ccc([O-])cc2)[NH+]1c1ccc(F)cc1,"InChI=1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2",0,ezetimibe,,no
315,axumin,fluciclovine f-18,fluciclovine f-18,no,[NH3+]C1(C(=O)[O-])CC(F)C1,"InChI=1S/C5H8FNO2/c6-3-1-5(7,2-3)4(8)9/h3H,1-2,7H2,(H,8,9)",0,fluciclovine f-18,,no
316,deferasirox,deferasirox,deferasirox,no,O=C([O-])c1ccc(-n2nc(-c3ccccc3[O-])nc2-c2ccccc2[O-])cc1,"InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)/p-3",0,deferasirox,,CLINICAL PHARMACOLOGY
317,zypitamag,pitavastatin magnesium,pitavastatin,no,O=C([O-])CC(O)CC(O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,"InChI=1S/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/p-1",0,pitavastatin magnesium,,no
318,vitrakvi,larotrectinib,larotrectinib,no,O=C(Nc1cnn2ccc([NH+]3CCCC3c3cc(F)ccc3F)nc12)[NH+]1CCC(O)C1,"InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/p+2",0,larotrectinib,,CLINICAL PHARMACOLOGY
319,ismotic,isosorbide,isosorbide,no,OC1COC2C(O)COC12,"InChI=1S/C6H10O4/c7-3-1-9-6-4(8)2-10-5(3)6/h3-8H,1-2H2",0,isosorbide,,no
320,movantik,naloxegol oxalate,naloxegol oxalate,no,C=CC[NH+]1CCC23c4c5ccc([O-])c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,"InChI=1S/C34H53NO11/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2/h3-5,28-29,32,36-37H,1,6-25H2,2H3",0,naloxegol oxalate,,CLINICAL PHARMACOLOGY
321,ravicti,glycerol phenylbutyrate,glycerol phenylbutyrate,no,O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1,"InChI=1S/C33H38O6/c34-31(22-10-19-27-13-4-1-5-14-27)37-25-30(39-33(36)24-12-21-29-17-8-3-9-18-29)26-38-32(35)23-11-20-28-15-6-2-7-16-28/h1-9,13-18,30H,10-12,19-26H2",0,glycerol phenylbutyrate,,CLINICAL PHARMACOLOGY
322,pyrazinamide,pyrazinamide,pyrazinamide,no,NC(=O)c1cnccn1,"InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)",0,pyrazinamide,,no
323,carglumic acid,carglumic acid,carglumic acid,no,NC(=O)NC(CCC(=O)[O-])C(=O)[O-],"InChI=1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/p-2",0,carglumic acid,,CLINICAL PHARMACOLOGY
324,tenofovir disoproxil fumarate,tenofovir disoproxil fumarate,tenofovir disoproxil fumarate,no,CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(=N)[n-]cnc21)OCOC(=O)OC(C)C,"InChI=1S/C19H29N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H-,20,21,22)/q-1",0,tenofovir disoproxil fumarate,,no
325,vemlidy,tenofovir alafenamide,tenofovir alafenamide fumarate,no,CC(C)OC(=O)C(C)[NH2+]P(=O)(COC(C)Cn1cnc2c(=N)[n-]cnc21)Oc1ccccc1,"InChI=1S/C21H28N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H2-,22,23,24,26,29)/q-1/p+1",0,tenofovir alafenamide,,CLINICAL PHARMACOLOGY
326,nurtec odt,rimegepant sulfate,rimegepant sulfate,no,[NH3+]C1c2cccnc2C(OC(=O)[NH+]2CCC(n3c(=O)[n-]c4ncccc43)CC2)CCC1c1cccc(F)c1F,"InChI=1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/p+1",0,rimegepant sulfate,,CLINICAL PHARMACOLOGY
327,odomzo,sonidegib,sonidegib phosphate,no,Cc1c(C(=O)Nc2ccc(N3CC(C)OC(C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1,"InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)",0,sonidegib,,CLINICAL PHARMACOLOGY
328,ceftriaxone,ceftriaxone,ceftriaxone sodium,no,CON=C(C(O)=NC1C(=O)[NH+]2C(C(=O)[O-])=C(CSc3[n-]c(=O)c(=O)[n-][n+]3C)CSC12)c1csc(=N)[n-]1,"InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H5,19,20,21,22,27,28,31,32)/p-2",0,ceftriaxone,,no
329,tazicef,ceftazidime,ceftazidime,no,CC(C)(ON=C(C(=O)NC1C(=O)[NH+]2C(C(=O)[O-])=C(C[n+]3ccccc3)CSC12)c1csc(=N)[n-]1)C(=O)[O-],"InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/p-1",0,ceftazidime,,no
330,clorazepate dipotassium,clorazepate dipotassium,clorazepate dipotassium,no,O=c1nc2ccc(Cl)cc2c(-c2ccccc2)nc1C(O)O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,16,21-22H",0,clorazepate dipotassium,,no
331,nevirapine,nevirapine,nevirapine hemihydrate,no,Cc1ccnc2c1NC(=O)c1cccnc1[NH+]2C1CC1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)/p+1",0,nevirapine,,no
332,kengreal,cangrelor,cangrelor,no,CSCC[NH+]=C1NC(=[S+]CCC(F)(F)F)[NH+]=C2C1=NC=[N+]2C1OC(CO[P-](=O)(=O)O[P-](=O)(=O)C(Cl)(Cl)[P](=O)(=O)O)C(O)C1O,"InChI=1S/C17H22Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,23,25)(H,30,31,32)/p+2",0,cangrelor,,no
333,kit for the preparation of technetium tc 99m medronate,technetium tc 99m medronate,technetium tc-99m medronate,no,O=[P](=O)(O)C[P](=O)(=O)O,"InChI=1S/CH4O6P2/c2-8(3,4)1-9(5,6)7/h1H2,(H,2,3,4)(H,5,6,7)",0,technetium tc 99m medronate,,no
334,miglitol,miglitol,miglitol,no,OCC[NH+]1CC(O)C(O)C(O)C1CO,"InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/p+1",0,miglitol,,no
335,xyrem,sodium oxybate,sodium oxybate,no,O=C([O-])CCCO,"InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)/p-1",0,sodium oxybate,,no
336,atovaquone,atovaquone,atovaquone,no,[O-]c1c(C2=CCC(c3ccc(Cl)cc3)CC2)c([O-])c2ccccc2c1[O-],"InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,7,9-13,24-26H,5-6,8H2/p-3",0,atovaquone,,no
337,tham,tromethamine,tromethamine,no,[NH3+]C(CO)(CO)CO,"InChI=1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2/p+1",0,tromethamine,,no
338,vigabatrin,vigabatrin,vigabatrin,no,C=CC([NH3+])CCC(=O)[O-],"InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)",0,vigabatrin,,no
339,jardiance,empagliflozin,empagliflozin,no,OCC1OC(c2ccc(Cl)c(Cc3ccc(OC4CCOC4)cc3)c2)C(O)C(O)C1O,"InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2",0,empagliflozin,,no
340,lactulose,lactulose,lactulose,no,OCC1OC(OC2C(CO)OC(O)(CO)C2O)C(O)C(O)C1O,"InChI=1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2",0,lactulose,,no
341,endari,glutamine,glutamine,no,NC(=O)CCC([NH3+])C(=O)[O-],"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)",0,glutamine,,no
342,leukeran,chlorambucil,chlorambucil,no,O=C([O-])CCCc1ccc(N(CCCl)CCCl)cc1,"InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)/p-1",0,chlorambucil,,no
343,motegrity,prucalopride,prucalopride succinate,no,COCCC[NH+]1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1,"InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)/p+1",0,prucalopride,,CLINICAL PHARMACOLOGY
344,krintafel,tafenoquine succinate,tafenoquine succinate,no,COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc([NH2+]C(C)CCC[NH3+])c2n1,"InChI=1S/C24H28F3N3O3/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3/p+2",0,tafenoquine succinate,,CLINICAL PHARMACOLOGY
345,atorvastatin calcium,atorvastatin calcium,atorvastatin calcium trihydrate,no,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)[O-],"InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/p-1",0,atorvastatin calcium,,no
346,ampicillin,ampicillin,ampicillin trihydrate,no,CC1(C)SC2C(NC(=O)C([NH3+])c3ccccc3)C(=O)[NH+]2C1C(=O)[O-],"InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/p+1",0,ampicillin,,no
347,alendronate,alendronate sodium,alendronate sodium,no,[NH3+]CCCC(O)([P](=O)(=O)O)[P](=O)(=O)O,"InChI=1S/C4H11NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H,7,8,9)(H,10,11,12)/p+1",0,alendronate sodium,,no
348,quazepam,quazepam,quazepam,no,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,"InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2",0,quazepam,,no
349,triamterene,triamterene capsules,triamterene,no,N=c1[n-]c(=N)c2nc(-c3ccccc3)c(=N)[n-]c2[n-]1,"InChI=1S/C12H8N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H3-3,13,14,15,17,18,19)/q-3",0,triamterene capsules,,no
350,thiamine hydrochloride,thiamine hydrochloride,thiamine hydrochloride,no,Cc1nc(=N)c(C[n+]2csc(CCO)c2C)c[n-]1,"InChI=1S/C12H16N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H-,13,14,15)",0,thiamine hydrochloride,,no
351,erivedge,vismodegib,vismodegib,no,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,"InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)",0,vismodegib,,CLINICAL PHARMACOLOGY
352,neomycin sulfate,neomycin sulfate,neomycin sulfate,no,[NH3+]CC1OC(OC2C(CO)OC(OC3C(O)C([NH3+])CC([NH3+])C3OC3OC(C[NH3+])C(O)C(O)C3[NH3+])C2O)C([NH3+])C(O)C1O,"InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/p+6",0,neomycin sulfate,,no
353,sevelamer hydrochloride,sevelamer hydrochloride,sevelamer hydrochloride,no,C=CC[NH3+],"InChI=1S/C3H7N/c1-2-3-4/h2H,1,3-4H2/p+1",0,sevelamer hydrochloride,,no
354,fenofibric acid,fenofibric acid,choline fenofibrate,no,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)[O-],"InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)/p-1",0,fenofibric acid,,no
355,cystadane,betaine,betaine,no,C[N+](C)(C)CC(=O)[O-],"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3",0,betaine,,no
356,levocarnitine,levocarnitine,levocarnitine,no,C[N+](C)(C)CC(O)CC(=O)[O-],"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3",0,levocarnitine,,no
357,choline c 11,choline c-11,choline c-11,no,C[N+](C)(C)CCO,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1",0,choline c-11,,no
358,acarbose,acarbose,acarbose,no,CC1OC(OC2C(CO)OC(OC(C(=O)C(O)CO)C(O)CO)C(O)C2O)C(O)C(O)C1[NH2+]C1C=C(CO)C(O)C(O)C1O,"InChI=1S/C25H43NO18/c1-7-13(26-9-2-8(3-27)14(33)18(37)15(9)34)17(36)20(39)24(41-7)44-23-12(6-30)42-25(21(40)19(23)38)43-22(11(32)5-29)16(35)10(31)4-28/h2,7,9-15,17-34,36-40H,3-6H2,1H3/p+1",0,acarbose,,no
359,imcivree,setmelanotide,setmelanotide,no,CC(=O)NC(CCC[NH+]=C(N)N)C(=O)NC1CSSCC(C(N)=O)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC[NH+]=C(N)N)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2cnc[n-]2)NC(=O)C(C)NC1=O,"InChI=1S/C49H68N18O9S2/c1-26-41(70)63-37(20-30-22-55-25-59-30)46(75)64-35(18-28-10-4-3-5-11-28)44(73)62-34(15-9-17-57-49(53)54)43(72)65-36(19-29-21-58-32-13-7-6-12-31(29)32)45(74)66-38(40(50)69)23-77-78-24-39(47(76)60-26)67-42(71)33(61-27(2)68)14-8-16-56-48(51)52/h3-7,10-13,21-22,25-26,33-39,58H,8-9,14-20,23-24H2,1-2H3,(H19,50,51,52,53,54,55,56,57,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76)/p+1",0,setmelanotide,,no
360,apretude,cabotegravir,cabotegravir sodium,no,CC1COC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)[NH+]12,"InChI=1S/C19H17F2N3O5/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27)",0,cabotegravir,,CLINICAL PHARMACOLOGY
361,copiktra,duvelisib,duvelisib,no,CC(N=c1[n-]cnc2[n-]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,"InChI=1S/C22H15ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3/q-2",0,duvelisib,,CLINICAL PHARMACOLOGY
362,chenodal,chenodiol,chenodiol,no,CC(CCC(=O)[O-])C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,"InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/p-1",0,chenodiol,,no
363,oxandrolone,oxandrolone,oxandrolone,no,CC12COC(=O)CC1CCC1C2CCC2(C)C1CCC2(C)O,"InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3",0,oxandrolone,,no
364,qulipta,atogepant,atogepant,no,Cc1c(-c2c(F)ccc(F)c2F)cc(NC(=O)C2CN=C3CC4(CC3C2)C(=O)Nc2ncccc24)c(=O)n1CC(F)(F)F,"InChI=1S/C29H23F6N5O3/c1-13-16(22-18(30)4-5-19(31)23(22)32)8-20(26(42)40(13)12-29(33,34)35)38-25(41)15-7-14-9-28(10-21(14)37-11-15)17-3-2-6-36-24(17)39-27(28)43/h2-6,8,14-15H,7,9-12H2,1H3,(H,38,41)(H,36,39,43)",0,atogepant,,CLINICAL PHARMACOLOGY
365,ubrelvy,ubrogepant,ubrogepant,no,Cc1c(-c2ccccc2)cc(NC(=O)C2CN=C3CC4(CC3C2)C(=O)Nc2ncccc24)c(=O)n1CC(F)(F)F,"InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-9,11,18-19H,10,12-15H2,1H3,(H,35,38)(H,33,36,40)",0,ubrogepant,,CLINICAL PHARMACOLOGY
366,lanthanum carbonate,lanthanum carbonate,lanthanum carbonate,no,O=C([O-])[O-],"InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-2",0,lanthanum carbonate,,no
367,fludeoxyglucose f 18,fludeoxyglucose f-18,fludeoxyglucose f-18,no,OCC1OC(O)C(F)C(O)C1O,"InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2",0,fludeoxyglucose f-18,,no
368,tazverik,tazemetostat,tazemetostat hydrobromide,no,CC[NH+](c1cc(-c2ccc(C[NH+]3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[n-]c2=O)c1C)C1CCOCC1,"InChI=1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H2,35,36,39,40)/p+1",0,tazemetostat,,CLINICAL PHARMACOLOGY
369,benznidazole,benznidazole,benznidazole,no,O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1,"InChI=1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)",0,benznidazole,,no
370,orfadin,nitisinone,nitisinone,no,O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-],"InChI=1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2",0,nitisinone,,no
371,chloramphenicol sodium succinate,chloramphenicol sodium succinate,chloramphenicol sodium succinate,no,O=C([O-])CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,"InChI=1S/C15H16Cl2N2O8/c16-14(17)15(24)18-10(7-27-12(22)6-5-11(20)21)13(23)8-1-3-9(4-2-8)19(25)26/h1-4,10,13-14,23H,5-7H2,(H,18,24)(H,20,21)/p-1",0,chloramphenicol sodium succinate,,no
372,rabeprazole sodium,rabeprazole sodium,rabeprazole sodium,no,COCCCOc1ccnc(C[S+](O)c2nc3ccccc3[n-]2)c1C,"InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9,22H,5,10-12H2,1-2H3",0,rabeprazole sodium,,CLINICAL PHARMACOLOGY
373,orilissa,elagolix,elagolix sodium,no,COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(CC([NH2+]CCCC(=O)[O-])c3ccccc3)c2=O)c1F,"InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)",0,elagolix,,CLINICAL PHARMACOLOGY
374,paromomycin sulfate,paromomycin sulfate,paromomycin sulfate,no,[NH3+]CC1OC(OC2C(CO)OC(OC3C(O)C([NH3+])CC([NH3+])C3OC3OC(CO)C(O)C(O)C3[NH3+])C2O)C([NH3+])C(O)C1O,"InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/p+5",0,paromomycin sulfate,,no
375,illuccix,kit for the preparation of gallium ga 68 gozetotide injection,gozetotide,no,O=C([O-])CCc1ccc([O-])c(C[NH+](CC[NH+](CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)[O-])C(=O)[O-])C(=O)[O-])ccc2[O-])CC(=O)[O-])c1,"InChI=1S/C44H62N6O17/c51-34-13-8-28(22-30(34)24-49(26-40(59)60)20-21-50(27-41(61)62)25-31-23-29(9-14-35(31)52)11-16-38(55)56)10-15-37(54)46-18-4-1-2-7-36(53)45-19-5-3-6-32(42(63)64)47-44(67)48-33(43(65)66)12-17-39(57)58/h8-9,13-14,22-23,32-33,51-52H,1-7,10-12,15-21,24-27H2,(H,45,53)(H,46,54)(H,55,56)(H,57,58)(H,59,60)(H,61,62)(H,63,64)(H,65,66)(H2,47,48,67)/p-6",0,kit for the preparation of gallium ga 68 gozetotide injection,,no
376,cedax,ceftibuten dihydrate,ceftibuten dihydrate,no,N=c1[n-]c(C(CCC(=O)[O-])C(=O)N=C2C(=O)[NH+]3C(C(=O)[O-])=CCSC23)cs1,"InChI=1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h3,5-6,13H,1-2,4H2,(H4,16,17,20,21,24,25)/p-2",0,ceftibuten dihydrate,,no
377,oxbryta,voxelotor,voxelotor,no,CC(C)n1nccc1-c1ncccc1COc1cccc([O-])c1C=O,"InChI=1S/C19H19N3O3/c1-13(2)22-16(8-10-21-22)19-14(5-4-9-20-19)12-25-18-7-3-6-17(24)15(18)11-23/h3-11,13,24H,12H2,1-2H3/p-1",0,voxelotor,,CLINICAL PHARMACOLOGY
378,uptravi; uptravi titration pack,selexipag,selexipag,no,CC(C)[NH+](CCCCOCC(=O)[N-]S(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,"InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)",0,selexipag,,CLINICAL PHARMACOLOGY
379,prezista,darunavir,darunavir ethanolate,no,CC(C)C[NH+](CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,"InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/p+1",0,darunavir,,CLINICAL PHARMACOLOGY
380,tybost,cobicistat,cobicistat,no,CC(C)c1nc(C[NH+](C)C(=O)NC(CC[NH+]2CCOCC2)C(=O)NC(CCC(Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,"InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/p+2",0,cobicistat,,no
381,rosuvastatin,rosuvastatin,rosuvastatin,no,CC(C)=c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1=CCC(O)CC(O)CC(=O)[O-],"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-8,10,16-17,27-28H,9,11-12H2,1-4H3,(H,29,30)/p-1",0,rosuvastatin,,no
382,ninlaro,ixazomib,ixazomib citrate,no,CC(C)CC(NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(=O)[O-])(CC(=O)[O-])O1,"InChI=1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-19(32)20(34-21,7-16(27)28)8-17(29)30)25-15(26)9-24-18(31)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,31)(H,25,26)(H,27,28)(H,29,30)/p-2",0,ixazomib,,CLINICAL PHARMACOLOGY
383,molnupiravir,molnupiravir,molnupiravir,no,CC(C)C(=O)OCC1OC(n2ccc(=NO)[n-]c2=O)C(O)C1O,"InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18H,5H2,1-2H3,(H2,14,15,20,21)/p-1",0,molnupiravir,,no
384,horizant,gabapentin enacarbil,gabapentin enacarbil,no,CC(OC(=O)NCC1(CC(=O)[O-])CCCCC1)OC(=O)C(C)C,"InChI=1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)/p-1",0,gabapentin enacarbil,,CLINICAL PHARMACOLOGY
385,nateglinide,nateglinide,nateglinide,no,CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)[O-])CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/p-1",0,nateglinide,,no
386,penicillamine,penicillamine,penicillamine,no,CC(C)(S)C([NH3+])C(=O)[O-],"InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)",0,penicillamine,,no
387,pantoprazole sodium,pantoprazole,pantoprazole sodium,no,COc1ccnc(C[S+](O)c2nc3cc(OC(F)F)ccc3[n-]2)c1OC,"InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15,22H,8H2,1-2H3",0,pantoprazole,,no
388,hepsera,adefovir dipivoxil,adefovir dipivoxil,no,CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(=N)[n-]cnc21)OCOC(=O)C(C)(C)C,"InChI=1S/C20H31N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H-,21,22,23)/q-1",0,adefovir dipivoxil,,no
389,durlaza,acetylsalicylic acid,aspirin,no,CC(=O)Oc1ccccc1C(=O)[O-],"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)/p-1",0,acetylsalicylic acid,,no
390,alinia,nitazoxanide,nitazoxanide,no,CC(=O)Oc1ccccc1C(=O)N=c1[n-]cc([N+](=O)[O-])s1,"InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)/p-1",0,nitazoxanide,,no
391,xuriden,uridine triacetate,uridine triacetate,no,CC(=O)OCC1OC(n2ccc(=O)[n-]c2=O)C(OC(C)=O)C1OC(C)=O,"InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/p-1",0,uridine triacetate,,no
392,heparin sodium,heparin sodium,heparin sodium,no,CC(=O)NC1C(O)OC(COS(=O)(=O)[O-])C(OC2OC(C(=O)[O-])C(OC3OC(CO)C(OC4OC(C(=O)[O-])C(O)C(O)C4OS(=O)(=O)[O-])C(OS(=O)(=O)[O-])C3NS(=O)(=O)[O-])C(O)C2OS(=O)(=O)[O-])C1O,"InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)/p-7",0,heparin sodium,,no
393,acetazolamide,acetazolamide,acetazolamide,no,CC(=O)N=c1[n-]nc(S(N)(=O)=O)s1,"InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H3,5,6,7,9,10,11)/p-1",0,acetazolamide,,no
394,ibrance,palbociclib,palbociclib,no,CC(=O)c1c(C)c2c[n-]c(=Nc3ccc(N4CC[NH2+]CC4)cn3)nc2n(C2CCCC2)c1=O,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29,32,33)",0,palbociclib,,CLINICAL PHARMACOLOGY
395,elmiron,pentosan polysulfate sodium,pentosan polysulfate sodium,no,O=S(=O)([O-])OC1C(O)COC(OC2COC(O)C(OS(=O)(=O)[O-])C2OS(=O)(=O)[O-])C1OS(=O)(=O)[O-],"InChI=1S/C10H18O21S4/c11-3-1-26-10(8(31-35(22,23)24)5(3)28-32(13,14)15)27-4-2-25-9(12)7(30-34(19,20)21)6(4)29-33(16,17)18/h3-12H,1-2H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)/p-4",0,pentosan polysulfate sodium,,no
396,hiprex,methenamine hippurate,methenamine hippurate,no,O=C([O-])CNC(=O)c1ccccc1,"InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)/p-1",0,methenamine hippurate,,no
397,capastat sulfate,capreomycin,capreomycin sulfate,no,NC(=O)N=CC1NC(=O)C(CNC(=O)CC([NH3+])CCC[NH3+])NC(=O)C(CO)NC(=O)C([NH3+])CNC(=O)C(C2CC[NH+]=C(N)N2)NC1=O,"InChI=1S/C25H44N14O8/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14/h9,11-16,18,40H,1-8,10,26-28H2,(H2,30,47)(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)/p+4",0,capreomycin,,no
398,diacomit,stiripentol,stiripentol,no,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,"InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3",0,stiripentol,,no
399,cefizox,ceftizoxime sodium,ceftizoxime sodium,no,CON=C(C(=O)NC1C(=O)[NH+]2C(C(=O)[O-])=CCSC12)c1csc(=N)[n-]1,"InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H4,14,15,16,19,21,22)/p-1",0,ceftizoxime sodium,,no
400,glofil-125,sodium iothalamate i-125 injection,iothalamate sodium i-125,no,CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)[O-])c1I,"InChI=1S/C11H9I3N2O4/c1-3(17)16-9-7(13)4(10(18)15-2)6(12)5(8(9)14)11(19)20/h1-2H3,(H,15,18)(H,16,17)(H,19,20)/p-1",0,sodium iothalamate i-125 injection,,no
401,isosulfan blue,isosulfan blue,isosulfan blue,no,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(S(=O)(=O)[O-])ccc2S(=O)(=O)[O-])cc1,"InChI=1S/C27H32N2O6S2/c1-5-28(6-2)22-13-9-20(10-14-22)27(21-11-15-23(16-12-21)29(7-3)8-4)25-19-24(36(30,31)32)17-18-26(25)37(33,34)35/h9-19H,5-8H2,1-4H3,(H-,30,31,32,33,34,35)/p-1",0,isosulfan blue,,no
402,fulvestrant,fulvestrant,fulvestrant,no,CC12CCC3c4ccc([O-])cc4CC(CCCCCCCCC[S+](O)CCCC(F)(F)C(F)(F)F)C3C1CCC2O,"InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,39-40H,2-10,13-20H2,1H3",0,fulvestrant,,no
403,levonorgestrel,levonorgestrel,levonorgestrel,no,C#CC1(O)CCC2C3CC=C4CC(=O)CCC4C3CCC21CC,"InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,5,16-19,23H,3,6-13H2,1H3",0,levonorgestrel,,no
404,jencycla,norethindrone,norethindrone,no,C#CC1(O)CCC2C3CC=C4CC(=O)CCC4C3CCC21C,"InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,4,15-18,22H,5-12H2,2H3",0,norethindrone,,no
405,slynd,drospirenone,drospirenone,no,CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,"InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3",0,drospirenone,,no
406,cerianna,fluoroestradiol f 18,fluoroestradiol f-18,no,CC12CCC3c4ccc([O-])cc4CCC3C1CC(F)C2O,"InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/p-1",0,fluoroestradiol f 18,,no
407,tpoxx,tecovirimat monohydrate,tecovirimat monohydrate,no,O=C(Nn1c([O-])c2c(c1[O-])C1C=CC2C2CC12)c1ccc(C(F)(F)F)cc1,"InChI=1S/C19H15F3N2O3/c20-19(21,22)9-3-1-8(2-4-9)16(25)23-24-17(26)14-10-5-6-11(13-7-12(10)13)15(14)18(24)27/h1-6,10-13,26-27H,7H2,(H,23,25)/p-2",0,tecovirimat monohydrate,,CLINICAL PHARMACOLOGY
408,ascor,ascorbic acid,ascorbic acid,no,[O-]c1oc(C(O)CO)c([O-])c1[O-],"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,7-11H,1H2/p-3",0,ascorbic acid,,no
409,gemtesa,vibegron,vibegron,no,O=C(Nc1ccc(CC2CCC(C(O)c3ccccc3)[NH2+]2)cc1)C1CCc2nccc(=O)n21,"InChI=1S/C26H28N4O3/c31-24-14-15-27-23-13-12-22(30(23)24)26(33)29-19-8-6-17(7-9-19)16-20-10-11-21(28-20)25(32)18-4-2-1-3-5-18/h1-9,14-15,20-22,25,28,32H,10-13,16H2,(H,29,33)/p+1",0,vibegron,,CLINICAL PHARMACOLOGY
410,cholbam,cholic acid,cholic acid,no,CC(CCC(=O)[O-])C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,"InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/p-1",0,cholic acid,,no
411,ocaliva,obeticholic acid,obeticholic acid,no,CCC1C(O)C2C3CCC(C(C)CCC(=O)[O-])C3(C)CCC2C2(C)CCC(O)CC12,"InChI=1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/p-1",0,obeticholic acid,,CLINICAL PHARMACOLOGY
412,valstar,valrubicin,valrubicin,no,CCCCC(=O)OCC(=O)C1(O)C=C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)c2c(c([O-])c3c([O-])c4cccc(OC)c4c([O-])c3c2[O-])C1,"InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,12,14,17,22,27,41-45,47H,4-5,9-11,13H2,1-3H3,(H,38,46)/p-4",0,valrubicin,,no
413,radiogardase,prussian blue insoluble capsules,ferric ferrocyanide,no,C#N,InChI=1S/CHN/c1-2/h1H,0,prussian blue insoluble capsules,,no
414,livmarli,maralixibat chloride,maralixibat chloride,no,CCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2C(c2ccc(OCc3ccc(C[N+]45CC[NH+](CC4)CC5)cc3)cc2)C1O,"InChI=1S/C40H56N3O4S/c1-5-7-19-40(20-8-6-2)30-48(45,46)37-18-15-34(41(3)4)27-36(37)38(39(40)44)33-13-16-35(17-14-33)47-29-32-11-9-31(10-12-32)28-43-24-21-42(22-25-43)23-26-43/h9-18,27,38-39,44H,5-8,19-26,28-30H2,1-4H3/q+1/p+1",0,maralixibat chloride,,no
415,pryidostigmine bromide,pyridostigmine bromide,pyridostigmine bromide,no,C[n+]1cccc(OC(=O)[NH+](C)C)c1,"InChI=1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1/p+1",0,pyridostigmine bromide,,no
416,ridaura,auranofin,auranofin,no,CC(=O)OCC1OC(S)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O,"InChI=1S/C14H20O9S/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18/h10-14,24H,5H2,1-4H3",0,auranofin,,no
417,tauvid,flortaucipir f-18,flortaucipir f-18,no,Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1,"InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H",0,flortaucipir f-18,,no
418,indium in 111 oxyquinoline,indium in-111 oxyquinoline,indium in-111 oxyquinoline,no,[O-]c1cccc2cccnc12,"InChI=1S/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H/p-1",0,indium in-111 oxyquinoline,,no
419,accrufer,ferric maltol,ferric maltol,no,Cc1occc(=O)c1[O-],"InChI=1S/C6H6O3/c1-4-6(8)5(7)2-3-9-4/h2-3,8H,1H3/p-1",0,ferric maltol,,no
420,livtencity,maribavir,maribavir,no,CC(C)N=c1[n-]c2cc(Cl)c(Cl)cc2n1C1OC(CO)C(O)C1O,"InChI=1S/C15H18Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3/q-1",0,maribavir,,CLINICAL PHARMACOLOGY
421,xofluza,baloxavir marboxil,baloxavir marboxil,no,COC(=O)OCOc1c2n(ccc1=O)[NH+](C1c3ccccc3SCc3c1ccc(F)c3F)C1COCC[NH+]1C2=O,"InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/p+2",0,baloxavir marboxil,,CLINICAL PHARMACOLOGY
422,ic-green,indocyanine green,indocyanine green,no,CC1(C)C(=CC=CC=CC=CC2=[N+](CCCCS(=O)(=O)[O-])c3ccc4ccccc4c3C2(C)C)N(CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21,"InChI=1S/C43H48N2O6S2/c1-42(2)38(44(28-14-16-30-52(46,47)48)36-26-24-32-18-10-12-20-34(32)40(36)42)22-8-6-5-7-9-23-39-43(3,4)41-35-21-13-11-19-33(35)25-27-37(41)45(39)29-15-17-31-53(49,50)51/h5-13,18-27H,14-17,28-31H2,1-4H3,(H-,46,47,48,49,50,51)/p-1",0,indocyanine green,,no
423,warfarin sodium,warfarin sodium,warfarin sodium,no,CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3/p-1",0,warfarin sodium,,no
424,technescan hdp,technetium tc 99m oxidronate,oxidronate disodium,no,O=[P](=O)(O)C(O)[P](=O)(=O)O,"InChI=1S/CH4O7P2/c2-1(9(3,4)5)10(6,7)8/h1-2H,(H,3,4,5)(H,6,7,8)",0,technetium tc 99m oxidronate,,no
425,membraneblue,trypan blue,trypan blue,no,Cc1cc(-c2ccc(N=Nc3c(S(=O)(=O)[O-])cc4cc(S(=O)(=O)[O-])cc(N)c4c3[O-])c(C)c2)ccc1N=Nc1c(S(=O)(=O)[O-])cc2cc(S(=O)(=O)[O-])cc(N)c2c1[O-],"InChI=1S/C34H28N6O14S4/c1-15-7-17(3-5-25(15)37-39-31-27(57(49,50)51)11-19-9-21(55(43,44)45)13-23(35)29(19)33(31)41)18-4-6-26(16(2)8-18)38-40-32-28(58(52,53)54)12-20-10-22(56(46,47)48)14-24(36)30(20)34(32)42/h3-14,41-42H,35-36H2,1-2H3,(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)/p-6",0,trypan blue,,no
426,cefazolin,cefazolin,cefazolin sodium,no,Cc1nnc(SC=C2CSC3C(NC(=O)Cn4cnnn4)C(=O)[NH+]3C2C(=O)[O-])s1,"InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h4-5,9-10,12H,2-3H2,1H3,(H,16,23)(H,25,26)",0,cefazolin,,no
427,pipracil,piperacillin sodium,piperacillin sodium,no,CC[NH+]1CC[NH+](C(=O)NC(C(=O)NC2C(=O)[NH+]3C2SC(C)(C)C3C(=O)[O-])c2ccccc2)C(=O)C1=O,"InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/p+2",0,piperacillin sodium,,no
428,tivicay; tivicay pd,dolutegravir sodium,dolutegravir sodium,no,CC1CCOC2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)[NH+]12,"InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)",0,dolutegravir sodium,,CLINICAL PHARMACOLOGY
429,nulibry,fosdenopterin hydrobromide,fosdenopterin hydrobromide,no,N=c1[n-]c2c(c(=O)[n-]1)[NH2+]C1C([NH2+]2)OC2COP([O])(=O)OC2C1(O)O,"InChI=1S/C10H12N5O8P/c11-9-14-6-3(7(16)15-9)12-4-8(13-6)22-2-1-21-24(19,20)23-5(2)10(4,17)18/h2,4-5,8,12,17-18H,1H2,(H3-,11,13,14,15,16)/q-1/p+1",0,fosdenopterin hydrobromide,,CLINICAL PHARMACOLOGY
430,cefuroxime sodium,cefuroxime sodium,cefuroxime sodium,no,CON=C(C(=O)NC1C(=O)[NH+]2C(C(=O)[O-])=C(COC(N)=O)CSC12)c1ccco1,"InChI=1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)",0,cefuroxime sodium,,no
431,gavilax,gavilax,polyethylene glycol 3350,no,OCCO,"InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2",0,gavilax,NA,NA
432,doptelet,avatrombopag maleate,avatrombopag maleate,no,O=C(N=c1[n-]c(-c2cc(Cl)cs2)c(N2CC[NH+](C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)[O-])CC2)c(Cl)c1,"InChI=1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H2,33,34,38,39,40)/p-1",0,avatrombopag maleate,,CLINICAL PHARMACOLOGY
433,nerlynx,neratinib,neratinib maleate,no,CCOc1cc2[n-]cc(C#N)c(=Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CC[NH+](C)C,"InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18,32H,4,13,19H2,1-3H3,(H,36,38)",0,neratinib,,CLINICAL PHARMACOLOGY
434,cefprozil,cefprozil,cefprozil,no,CC=CC1=C(C(=O)[O-])[NH+]2C(=O)C(NC(=O)C([NH3+])c3ccc([O-])cc3)C2SC1,"InChI=1S/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)",0,cefprozil,,no
435,amoxicillin,amoxicillin,amoxicillin,no,CC1(C)SC2C(NC(=O)C([NH3+])c3ccc([O-])cc3)C(=O)[NH+]2C1C(=O)[O-],"InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)",0,amoxicillin,,no
436,etoposide,etoposide,etoposide,no,COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1[O-],"InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/p-1",0,etoposide,,no
437,brexafemme,ibrexafungerp,ibrexafungerp citrate,no,CC(C)C(C)C1(C)CCC2(C)C3CCC4C5(COCC4(C)C(OCC(C)([NH3+])C(C)(C)C)C(n4ncnc4-c4ccncc4)C5)C3=CCC2(C)C1C(=O)[O-],"InChI=1S/C44H67N5O4/c1-27(2)28(3)39(7)18-19-41(9)30-12-13-33-40(8)23-52-25-44(33,31(30)14-17-42(41,10)34(39)37(50)51)22-32(35(40)53-24-43(11,45)38(4,5)6)49-36(47-26-48-49)29-15-20-46-21-16-29/h14-16,20-21,26-28,30,32-35H,12-13,17-19,22-25,45H2,1-11H3,(H,50,51)",0,ibrexafungerp,,CLINICAL PHARMACOLOGY
438,lovastatin,lovastatin,lovastatin,no,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,"InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3",0,lovastatin,,no
439,colesevelam,colesevelam,colesevelam hydrochloride,no,C=CC[NH2+]CCCCCC[N+](C)(C)C,"InChI=1S/C12H27N2/c1-5-10-13-11-8-6-7-9-12-14(2,3)4/h5,13H,1,6-12H2,2-4H3/q+1/p+1",0,colesevelam,,no
440,rimso-50,dimethyl sulfoxide,dimethyl sulfoxide,no,C[S+](C)O,"InChI=1S/C2H7OS/c1-4(2)3/h3H,1-2H3/q+1",0,dimethyl sulfoxide,,no
441,fenofibrate,fenofibrate,fenofibrate,no,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,"InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3",0,fenofibrate,,no
442,pifeltro,doravirine,doravirine,no,Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[n-]c1=O,"InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28)/p-1",0,doravirine,,CLINICAL PHARMACOLOGY
443,celontin,methsuximide,methsuximide,no,C[NH+]1C(=O)CC(C)(c2ccccc2)C1=O,"InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3/p+1",0,methsuximide,,no
444,zanosar,streptozocin,streptozocin,no,C[NH+](N=O)C(=O)NC(C=O)C(O)C(O)C(O)CO,"InChI=1S/C8H15N3O7/c1-11(10-18)8(17)9-4(2-12)6(15)7(16)5(14)3-13/h2,4-7,13-16H,3H2,1H3,(H,9,17)/p+1",0,streptozocin,,no
445,amondys 45,casimersen,casimersen,no,C[NH+](C)P(=O)(OCC1C[NH2+]CC(n2ccc(=N)[n-]c2=O)O1)[NH+]1CC[NH+](C(=O)OCCOCCOCCO)CC1,"InChI=1S/C22H40N7O9P/c1-26(2)39(33,37-17-18-15-24-16-20(38-18)29-4-3-19(23)25-21(29)31)28-7-5-27(6-8-28)22(32)36-14-13-35-12-11-34-10-9-30/h3-4,18,20,24,30H,5-17H2,1-2H3,(H2,23,25,31)/p+3",0,casimersen,,no
446,dacarbazine,dacarbazine,dacarbazine,no,C[NH+](C)N=Nc1[n-]cnc1C(N)=O,"InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H3,7,8,9,11,13)",0,dacarbazine,,no
447,gilotrif,afatinib,afatinib,no,C[NH+](C)C=CCC(=O)Nc1cc2c(=Nc3ccc(F)c(Cl)c3)[n-]cnc2cc1OC1CCOC1,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3,5-6,8,10-12,14,16H,4,7,9,13H2,1-2H3,(H2,27,28,29,30,32)",0,afatinib,,CLINICAL PHARMACOLOGY
448,tigecycline,tigecycline,tigecycline,no,CN(C)c1cc(NC(=O)C[NH2+]C(C)(C)C)c([O-])c2c([O-])c3c(cc12)CC1C([NH+](C)C)C(=O)C(C(N)=O)C(=O)C1(O)C3O,"InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h8,10,14,20-21,25,31,36-37,39,42H,9,11H2,1-7H3,(H2,30,41)(H,32,35)",0,tigecycline,,no
449,gleostine,lomustine,lomustine,no,O=N[NH+](CCCl)C(=O)NC1CCCCC1,"InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14)/p+1",0,lomustine,,no
450,chlorzoxazone,chlorzoxazone,chlorzoxazone,no,O=c1[n-]c2cc(Cl)ccc2o1,"InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)/p-1",0,chlorzoxazone,,no
451,desloratadine,desloratadine,desloratadine,no,Clc1ccc2c(c1)CCc1cccnc1C2=C1CC[NH2+]CC1,"InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2/p+1",0,desloratadine,,CLINICAL PHARMACOLOGY
452,xarelto; xarelto,rivaroxaban,rivaroxaban,no,O=C(NCC1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,"InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)",0,rivaroxaban,,no
453,lysodren,mitotane,mitotane,no,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,"InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H",0,mitotane,,no
454,galafold,migalastat hydrochloride,migalastat hydrochloride,no,OCC1[NH2+]CC(O)C(O)C1O,"InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/p+1",0,migalastat hydrochloride,,CLINICAL PHARMACOLOGY
455,nouress,cysteine hydrochloride,cysteine hydrochloride,no,[NH3+]C(CS)C(=O)[O-],"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)",0,cysteine hydrochloride,,no
456,r-gene,arginine hydrochloride,arginine hydrochloride,no,NC(=[NH2+])NCCCC([NH3+])C(=O)[O-],"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1",0,arginine hydrochloride,,no
457,primsol,trimethoprim hydrochloride,trimethoprim hydrochloride,no,COc1cc(Cc2c[n-]c(=N)[n-]c2=N)cc(OC)c1OC,"InChI=1S/C14H16N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H2-2,15,16,17,18)/q-2",0,trimethoprim hydrochloride,,no
458,tigan,trimethobenzamide hydrochloride,trimethobenzamide hydrochloride,no,COc1cc(C(=O)NCc2ccc(OCC[NH+](C)C)cc2)cc(OC)c1OC,"InChI=1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24)/p+1",0,trimethobenzamide hydrochloride,,no
459,chlordiazepoxide hydrochloride,chlordiazepoxide hydrochloride,chlordiazepoxide hydrochloride,no,C[NH+]=C1C=[N+](O)C(c2ccccc2)c2cc(Cl)ccc2N1,"InChI=1S/C16H15ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-10,16,21H,1H3,(H,18,19)/q+1/p+1",0,chlordiazepoxide hydrochloride,,no
460,ticlopidine hydrochloride,ticlopidine hydrochloride,ticlopidine hydrochloride,no,Clc1ccccc1C[NH+]1CCc2sccc2C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2/p+1",0,ticlopidine hydrochloride,,no
461,trientine hydrochloride,trientine hydrochloride,trientine hydrochloride,no,[NH3+]CC[NH2+]CC[NH2+]CC[NH3+],"InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2/p+4",0,trientine hydrochloride,,no
462,ibsrela,tenapanor hydrochloride,tenapanor hydrochloride,no,C[NH+]1Cc2c(Cl)cc(Cl)cc2C(c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc(C4C[NH+](C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1,"InChI=1S/C50H66Cl4N8O10S2/c1-61-31-43(41-27-37(51)29-47(53)45(41)33-61)35-7-5-9-39(25-35)73(65,66)59-15-19-71-23-21-69-17-13-57-49(63)55-11-3-4-12-56-50(64)58-14-18-70-22-24-72-20-16-60-74(67,68)40-10-6-8-36(26-40)44-32-62(2)34-46-42(44)28-38(52)30-48(46)54/h5-10,25-30,43-44,59-60H,3-4,11-24,31-34H2,1-2H3,(H2,55,57,63)(H2,56,58,64)/p+2",0,tenapanor hydrochloride,,CLINICAL PHARMACOLOGY
463,cysview,hexaminolevulinate hydrochloride,hexaminolevulinate hydrochloride,no,CCCCCCOC(=O)CCC(=O)C[NH3+],"InChI=1S/C11H21NO3/c1-2-3-4-5-8-15-11(14)7-6-10(13)9-12/h2-9,12H2,1H3/p+1",0,hexaminolevulinate hydrochloride,,no
464,clindamycin palmitate hydrochloride,clindamycin palmitate hydrochloride,clindamycin palmitate hydrochloride,no,CCCCCCCCCCCCCCCC(=O)OC1C(SC)OC(C(NC(=O)C2CC(CCC)C[NH+]2C)C(C)Cl)C(O)C1O,"InChI=1S/C34H63ClN2O6S/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41)/p+1",0,clindamycin palmitate hydrochloride,,no
465,clindamycin hydrochloride,clindamycin hydrochloride,clindamycin hydrochloride,no,CCCC1CC(C(=O)NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)[NH+](C)C1,"InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/p+1",0,clindamycin hydrochloride,,no
466,pyridoxine hci,pyridoxine hci,pyridoxine hydrochloride,no,Cc1ncc(CO)c(CO)c1[O-],"InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3/p-1",0,pyridoxine hci,,no
467,edurant,rilpivirine hydrochloride,rilpivirine hydrochloride,no,Cc1cc(C=CC#N)cc(C)c1N=c1cc[n-]c(=Nc2ccc(C#N)cc2)[n-]1,"InChI=1S/C22H16N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3/q-2",0,rilpivirine hydrochloride,,CLINICAL PHARMACOLOGY
468,hycamtin,topotecan,topotecan hydrochloride,no,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(C[NH+](C)C)c([O-])ccc3nc2-1,"InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3",0,topotecan,,no
469,methimazole,methimazole,methimazole,no,Cn1cc[n-]c1=S,"InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)/p-1",0,methimazole,,no
470,azathioprine,azathioprine,azathioprine,no,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[n-]cnc12,"InChI=1S/C9H6N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3/q-1",0,azathioprine,,no
471,clobazam,clobazam,clobazam,no,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,"InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3",0,clobazam,,CLINICAL PHARMACOLOGY
472,zepzelca,lurbinectedin,lurbinectedin,no,COc1ccc2[nH]c3c(c2c1)CC[NH2+]C31CSC2c3c(OC(C)=O)c(C)c4c(c3C(COC1=O)[NH+]1C(O)C3Cc5cc(C)c(OC)c([O-])c5C(C21)[NH+]3C)OCO4,"InChI=1S/C41H44N4O10S/c1-17-11-20-12-25-39(48)45-26-14-52-40(49)41(38-22(9-10-42-41)23-13-21(50-5)7-8-24(23)43-38)15-56-37(31(45)30(44(25)4)27(20)32(47)33(17)51-6)29-28(26)36-35(53-16-54-36)18(2)34(29)55-19(3)46/h7-8,11,13,25-26,30-31,37,39,42-43,47-48H,9-10,12,14-16H2,1-6H3/p+2",0,lurbinectedin,,CLINICAL PHARMACOLOGY
473,colchicine,colchicine,colchicine,no,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)",0,colchicine,,no
474,mytesi,crofelemer,crofelemer,no,COc1ccccc1CNC(=O)c1cc(-c2ccccc2)on1,"InChI=1S/C18H16N2O3/c1-22-16-10-6-5-9-14(16)12-19-18(21)15-11-17(23-20-15)13-7-3-2-4-8-13/h2-11H,12H2,1H3,(H,19,21)",0,crofelemer,NA,NA
475,ultramicrosize griseofulvin,ultramicrosize griseofulvin,griseofulvin,no,COC1=CC(=O)CC(C)C12Oc1c(Cl)c(OC)cc(OC)c1C2=O,"InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3",0,ultramicrosize griseofulvin,,no
476,etopophos,etoposide phosphate,etoposide phosphate,no,COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O[P](=O)(=O)O,"InChI=1S/C29H32O16P/c1-11-38-9-20-27(42-11)23(30)24(31)29(43-20)44-25-14-7-17-16(40-10-41-17)6-13(14)21(22-15(25)8-39-28(22)32)12-4-18(36-2)26(19(5-12)37-3)45-46(33,34)35/h4-7,11,15,20-25,27,29-31H,8-10H2,1-3H3,(H,33,34,35)",0,etoposide phosphate,,no
477,nelarabine,nelarabine,nelarabine,no,COc1[n-]c(=N)nc2c1ncn2C1OC(CO)C(O)C1O,"InChI=1S/C11H14N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H-,12,14,15)/q-1",0,nelarabine,,no
478,iressa,gefitinib,gefitinib,no,COc1cc2[n-]cnc(=Nc3ccc(F)c(Cl)c3)c2cc1OCCC[NH+]1CCOCC1,"InChI=1S/C22H23ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3/q-1/p+1",0,gefitinib,,no
479,colchicine,colchicine,colchiceine,no,COc1cc2ccc(=NC(C)=O)c3c(c2c(OC)c1OC)CCC(=O)C(O)C3,"InChI=1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h5,7,9,17,25H,6,8,10H2,1-4H3",0,colchicine,,no
480,vizimpro,dacomitinib,dacomitinib,no,COc1cc2[n-]cnc(=Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CC[NH+]1CCCCC1,"InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H2,27,28,29,30,32)",0,dacomitinib,,CLINICAL PHARMACOLOGY
481,viberzi,eluxadoline,eluxadoline,no,COc1ccc(C[NH+](C(=O)C([NH3+])Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[n-]2)cc1C(=O)[O-],"InChI=1S/C32H35N5O5/c1-18-12-23(29(34)38)13-19(2)24(18)15-26(33)31(39)37(17-21-10-11-28(42-4)25(14-21)32(40)41)20(3)30-35-16-27(36-30)22-8-6-5-7-9-22/h5-14,16,20,26H,15,17,33H2,1-4H3,(H4,34,35,36,38,40,41)",0,eluxadoline,,CLINICAL PHARMACOLOGY
482,vermox,mebendazole,mebendazole,no,COC(=O)N=c1[n-]c2ccc(C(=O)c3ccccc3)cc2[n-]1,"InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,20,21)/p-2",0,mebendazole,,no
483,bafiertam,monomethyl fumarate,monomethyl fumarate,no,COC(=O)C=CC(=O)[O-],"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/p-1",0,monomethyl fumarate,,CLINICAL PHARMACOLOGY
484,valacyclovir hydrochloride,valacyclovir,valacyclovir hydrochloride,no,CC(C)C([NH3+])C(=O)OCCOCn1cnc2c(=O)[n-]c(=N)[n-]c21,"InChI=1S/C13H19N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H2-,15,17,18,20)/q-1",0,valacyclovir,,no
485,vumerity,diroximel fumarate,diroximel fumarate,no,COC(=O)C=CC(=O)OCCn1c([O-])ccc1[O-],"InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h2-5,13-14H,6-7H2,1H3/p-2",0,diroximel fumarate,,CLINICAL PHARMACOLOGY
486,datscan,ioflupane i-123,ioflupane i-123,no,COC(=O)C1C(c2ccc(I)cc2)CC2CCC1[NH+]2CCCF,"InChI=1S/C18H23FINO2/c1-23-18(22)17-15(12-3-5-13(20)6-4-12)11-14-7-8-16(17)21(14)10-2-9-19/h3-6,14-17H,2,7-11H2,1H3/p+1",0,ioflupane i-123,,no
487,cefditoren pivoxil,cefditoren pivoxil,cefditoren pivoxil,no,CON=C(C(=O)NC1C(=O)[NH+]2C(C(=O)OCOC(=O)C(C)(C)C)=C(C=Cc3scnc3C)CSC12)c1csc(=N)[n-]1,"InChI=1S/C25H28N6O7S3/c1-12-15(41-10-27-12)7-6-13-8-39-21-17(29-19(32)16(30-36-5)14-9-40-24(26)28-14)20(33)31(21)18(13)22(34)37-11-38-23(35)25(2,3)4/h6-7,9-10,17,21H,8,11H2,1-5H3,(H3,26,28,29,32)",0,cefditoren pivoxil,,no
488,xifaxan,rifaximin,rifaximin,no,COC1C=COC2(C)Oc3c(C)c([O-])c4c([O-])c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,"InChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/p-2",0,rifaximin,,no
489,aemcolo,rifamycin,rifamycin,no,COC1C=COC2(C)Oc3c(C)c([O-])c4c([O-])c(cc([O-])c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,"InChI=1S/C37H47NO12/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46)/p-3",0,rifamycin,,no
490,cefotetan,cefotetan,cefotetan,no,COC1([NH2+]C(O)=c2sc(=C(C(N)=O)C(=O)[O-])s2)C(=O)[NH+]2C(C(=O)[O-])=C(CSc3nnnn3C)CSC21,"InChI=1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h15,19,26H,3-4H2,1-2H3,(H2,18,25)(H,27,28)(H,29,30)",0,cefotetan,,no
491,neuraceq,florbetaben f 18,florbetaben f-18,no,CNc1ccc(C=Cc2ccc(OCCOCCOCCF)cc2)cc1,"InChI=1S/C21H26FNO3/c1-23-20-8-4-18(5-9-20)2-3-19-6-10-21(11-7-19)26-17-16-25-15-14-24-13-12-22/h2-11,23H,12-17H2,1H3",0,florbetaben f 18,,no
492,fosaprepitant,fosaprepitant dimeglumine,fosaprepitant dimeglumine,no,CC(OC1OCC[NH+](Cc2nc(=O)n([P](=O)(=O)O)[n-]2)C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,"InChI=1S/C23H21F7N4O6P/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,35,36,37,38)",0,fosaprepitant dimeglumine,,no
493,tabrecta,capmatinib,capmatinib,no,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,"InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)",0,capmatinib,,CLINICAL PHARMACOLOGY
494,temodar,temozolomide,temozolomide,no,Cn1nnc2c(C(N)=O)ncn2c1=O,"InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)",0,temozolomide,,no
495,methazolamide,methazolamide,methazolamide,no,CC(=O)N=c1sc(S(N)(=O)=O)nn1C,"InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)",0,methazolamide,,no
496,cosela,trilaciclib,trilaciclib dihydrochloride,no,C[NH+]1CCN(c2ccc(N=c3nc4c(c[n-]3)cc3n4C4(CCCCC4)CNC3=O)nc2)CC1,"InChI=1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H2,25,26,27,28,29,33)",0,trilaciclib,,CLINICAL PHARMACOLOGY
497,tepmetko,tepotinib hydrochloride,tepotinib hydrochloride,no,C[NH+]1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,"InChI=1S/C29H28N6O2/c1-34-12-10-21(11-13-34)20-37-26-17-31-29(32-18-26)25-7-3-5-23(15-25)19-35-28(36)9-8-27(33-35)24-6-2-4-22(14-24)16-30/h2-9,14-15,17-18,21H,10-13,19-20H2,1H3/p+1",0,tepotinib hydrochloride,,CLINICAL PHARMACOLOGY
498,dimethyl fumarate,dimethyl fumarate,dimethyl fumarate,no,COC(=O)C=CC(=O)OC,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3",0,dimethyl fumarate,,CLINICAL PHARMACOLOGY
499,fexofenadine hydrochloride,fexofenadine hydrochloride,fexofenadine hydrochloride,no,CC(C)(C(=O)[O-])c1ccc(C(O)CCC[NH+]2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,"InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)",0,fexofenadine hydrochloride,,no
500,varubi,rolapitant,rolapitant hydrochloride,no,CC(OCC1(c2ccccc2)CCC2(CCC(=O)N2)C[NH2+]1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,"InChI=1S/C25H26F6N2O2/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34)/p+1",0,rolapitant,,CLINICAL PHARMACOLOGY
501,cholestyramine,cholestyramine,cholestyramine,no,CCC(CC(C)c1ccccc1)c1ccc(C[N+](C)(C)C)cc1,"InChI=1S/C22H32N/c1-6-20(16-18(2)21-10-8-7-9-11-21)22-14-12-19(13-15-22)17-23(3,4)5/h7-15,18,20H,6,16-17H2,1-5H3/q+1",0,cholestyramine,,no
502,ramelteon,ramelteon,ramelteon,no,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,"InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)",0,ramelteon,,no
503,hetlioz; hetlioz lq,tasimelteon,tasimelteon,no,CCC(=O)NCC1CC1c1cccc2c1CCO2,"InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)",0,tasimelteon,,no
504,triazolam,triazolam,triazolam,no,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",0,triazolam,,no
505,isentress,isentress,raltegravir potassium,no,Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1,"InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)/p-1",0,isentress,,CLINICAL PHARMACOLOGY
506,dayvigo,lemborexant,lemborexant,no,Cc1ncc(OCC2(c3cccc(F)c3)CC2C(=O)N=c2ccc(F)c[n-]2)c(C)n1,"InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/p-1",0,lemborexant,,CLINICAL PHARMACOLOGY
507,evrysdi,risdiplam,risdiplam,no,Cc1cn2nc(-c3cc(=O)n4cc(N5CC[NH2+]C6(CC6)C5)ccc4n3)cc(C)c2n1,"InChI=1S/C22H23N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3/p+1",0,risdiplam,,no
508,esbriet,pirfenidone,pirfenidone,no,Cc1ccc(=O)n(-c2ccccc2)c1,"InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3",0,pirfenidone,,CLINICAL PHARMACOLOGY
509,stavudine,stavudine,stavudine,no,Cc1cn(C2C=CC(CO)O2)c(=O)[n-]c1=O,"InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/p-1",0,stavudine,,no
510,savaysa,edoxaban tosylate,edoxaban tosylate,no,C[NH+]1CCc2nc(C(=O)NC3CC(C(=O)[NH+](C)C)CCC3NC(=O)C(=O)N=c3ccc(Cl)c[n-]3)sc2C1,"InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H3,26,27,28,30,33,34,35)/p+1",0,edoxaban tosylate,,CLINICAL PHARMACOLOGY
511,rapivab,peramivir,peramivir,no,CCC(CC)C(NC(C)=O)C1C([NH+]=C(N)N)CC(C(=O)[O-])C1O,"InChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)",0,peramivir,,CLINICAL PHARMACOLOGY
512,symproic,naldemedine,naldemedine tosylate,no,CC(C)(NC(=O)C1CC2(O)C3Cc4ccc([O-])c5c4C2(CC[NH+]3CC2CC2)C(O5)C1=O)c1nc(-c2ccccc2)no1,"InChI=1S/C32H34N4O6/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17/h3-7,10-11,17,20,22,26,37,40H,8-9,12-16H2,1-2H3,(H,34,39)",0,naldemedine,,CLINICAL PHARMACOLOGY
513,choletec,mebrofenin,mebrofenin,no,Cc1cc(C)c(NC(=O)C[NH+](CC(=O)[O-])CC(=O)[O-])c(C)c1Br,"InChI=1S/C15H19BrN2O5/c1-8-4-9(2)15(10(3)14(8)16)17-11(19)5-18(6-12(20)21)7-13(22)23/h4H,5-7H2,1-3H3,(H,17,19)(H,20,21)(H,22,23)/p-1",0,mebrofenin,,no
514,meclizine hydrochloride,meclizine hydrochloride,meclizine hydrochloride,no,Cc1cccc(C[NH+]2CC[NH+](C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,"InChI=1S/C25H27ClN2/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23/h2-13,18,25H,14-17,19H2,1H3/p+2",0,meclizine hydrochloride,,no
515,cephalexin,cephalexin,cephalexin,no,CC1=C(C(=O)[O-])[NH+]2C(=O)C(NC(=O)C([NH3+])c3ccccc3)C2SC1,"InChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/p+1",0,cephalexin,,no
516,invokana,canagliflozin,canagliflozin,no,Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,"InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3",0,canagliflozin,,CLINICAL PHARMACOLOGY
517,venclexta,venetoclax,venetoclax,no,CC1(C)CCC(C[NH+]2CCN(c3ccc(C(=O)[N-]S(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,"InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H2,47,49,50,54)",0,venetoclax,,CLINICAL PHARMACOLOGY
518,ursodiol,ursosiol,ursadiol,no,CC1(C)CCC2(C)C(=C3CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CC2O)C1,"InChI=1S/C30H50O2/c1-25(2)15-16-27(5)20(17-25)19-9-10-22-28(6)13-12-23(31)26(3,4)21(28)11-14-29(22,7)30(19,8)18-24(27)32/h21-24,31-32H,9-18H2,1-8H3",0,ursosiol,,no
519,zydelig,idelalisib,idelalisib,no,CCC(N=c1[n-]cnc2[n-]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,"InChI=1S/C22H16FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3/q-2",0,idelalisib,,CLINICAL PHARMACOLOGY
520,solosec,secnidazole,secnidazole,no,Cc1ncc([N+](=O)[O-])n1CC(C)O,"InChI=1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3",0,secnidazole,,CLINICAL PHARMACOLOGY
521,zileuton,zileuton,zileuton,no,CC(c1cc2ccccc2s1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",0,zileuton,,no
522,metaxalone,metaxalone,metaxalone,no,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,"InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)",0,metaxalone,,no
523,ukoniq,umbralisib,umbralisib tosylate,no,CC(C)Oc1ccc(-c2nn(C(C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3[n-]cnc(=N)c23)cc1F,"InChI=1S/C31H23F3N5O3/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29/h4-16H,1-3H3,(H-,35,36,37,38)/q-1",0,umbralisib,,CLINICAL PHARMACOLOGY
524,aptivus,tipranavir,tipranavir,no,CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,28,36H,3-4,15-17,19H2,1-2H3",0,tipranavir,,no
525,primidone,primidone,primidone,no,CCC1(c2ccccc2)C(=O)NCNC1=O,"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",0,primidone,,no
526,cefepime,cefepime,cefepime hydrochloride,no,CON=C(C(=O)NC1C(=O)[NH+]2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CSC12)c1csc(=N)[n-]1,"InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)",0,cefepime,,no
527,tobramycin,tobramycin sulfate,tobramycin sulfate,no,[NH3+]CC1OC(OC2C([NH3+])CC([NH3+])C(OC3OC(CO)C(O)C([NH3+])C3O)C2O)C([NH3+])CC1O,"InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/p+5",0,tobramycin sulfate,,no
528,kerendia,finerenone,finerenone,no,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)C(C)=N2,"InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,16-17H,5H2,1-4H3,(H2,23,26)",0,finerenone,,CLINICAL PHARMACOLOGY
529,farxiga,dapagliflozin,dapagliflozin propanediol,no,CCOc1ccc(Cc2cc(C3OC(CO)C(O)C(O)C3O)ccc2Cl)cc1,"InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3",0,dapagliflozin,,CLINICAL PHARMACOLOGY
530,steglatro,ertugliflozin,ertugliflozin pidolate,no,CCOc1ccc(Cc2cc(C34OCC(CO)(O3)C(O)C(O)C4O)ccc2Cl)cc1,"InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3",0,ertugliflozin,,CLINICAL PHARMACOLOGY
531,otezla,apremilast,apremilast,no,CCOc1cc(C(CS(C)(=O)=O)[NH+]2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,"InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/p+1",0,apremilast,,no
532,loratadine,loratadine,loratadine,no,CCOC(=O)[NH+]1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,"InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3/p+1",0,loratadine,,no
533,pepaxto,melphalan flufenamide,melphalan flufenamide hydrochloride,no,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C([NH3+])Cc1ccc(N(CCCl)CCCl)cc1,"InChI=1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/p+1",0,melphalan flufenamide,,no
534,xermelo,telotristat ethyl,telotristat ethyl,no,CCOC(=O)C([NH3+])Cc1ccc(-c2cc(OC(c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)[n-]c(=N)n2)cc1,"InChI=1S/C27H25ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H-,33,34,35)/q-1/p+1",0,telotristat ethyl,,CLINICAL PHARMACOLOGY
535,truseltiq,infigratinib,infigratinib,no,CC[NH+]1CCN(c2ccc(N=c3cc([NH+](C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)[n-]cn3)cc2)CC1,"InChI=1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9,14-16H,5,10-13H2,1-4H3,(H2,29,30,31,32,36)/p+1",0,infigratinib,,CLINICAL PHARMACOLOGY
536,nourianz,istradefylline,istradefylline,no,CCn1c(=O)c2c(nc(C=Cc3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,"InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3",0,istradefylline,,CLINICAL PHARMACOLOGY
537,peganone,ethotoin,ethotoin,no,CCn1c([O-])c(-c2ccccc2)[n-]c1=O,"InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,12,14,15)/p-2",0,ethotoin,,no
538,tissueblue,brilliant blue g,brilliant blue g,no,CCOc1ccc(Nc2ccc(C(=C3C=CC(=[N+](CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3C)c3ccc(N(CC)Cc4cccc(S(=O)(=O)[O-])c4)cc3C)cc2)cc1,"InChI=1S/C47H49N3O7S2/c1-6-49(31-35-11-9-13-43(29-35)58(51,52)53)40-21-25-45(33(4)27-40)47(37-15-17-38(18-16-37)48-39-19-23-42(24-20-39)57-8-3)46-26-22-41(28-34(46)5)50(7-2)32-36-12-10-14-44(30-36)59(54,55)56/h9-30H,6-8,31-32H2,1-5H3,(H2,51,52,53,54,55,56)/p-1",0,brilliant blue g,,no
539,briviact,brivaracetam,brivaracetam,no,CCCC1CC(=O)[NH+](C(CC)C(N)=O)C1,"InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/p+1",0,brivaracetam,,CLINICAL PHARMACOLOGY
540,albendazole,albendazole,albendazole,no,CCCSc1ccc2[n-]c(=NC(=O)OC)[n-]c2c1,"InChI=1S/C12H14N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H-,13,14,15,16)/q-1/p-1",0,albendazole,,no
541,probenecid,probenecid,probenecid,no,CCC[NH+](CCC)S(=O)(=O)c1ccc(C(=O)[O-])cc1,"InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)",0,probenecid,,no
542,benzonatate,benzonatate,benzonatate,no,CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,"InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3",0,benzonatate,,no
543,miglustat,miglustat,miglustat,no,CCCC[NH+]1CC(O)C(O)C(O)C1CO,"InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/p+1",0,miglustat,,no
544,mulpleta,lusutrombopag,lusutrombopag,no,CCCCCCOC(C)c1cccc(-c2csc(=NC(=O)c3cc(Cl)c(C=C(C)C(=O)[O-])c(Cl)c3)[n-]2)c1OC,"InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H2,32,33,34,35,36)/p-2",0,lusutrombopag,,CLINICAL PHARMACOLOGY
545,impavido,miltefosine,miltefosine,no,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,"InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3",0,miltefosine,,CLINICAL PHARMACOLOGY
546,xenical,orlistat,orlistat,no,CCCCCCCCCCCC(CC1OC(=O)C1CCCCCC)OC(=O)C(CC(C)C)NC=O,"InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)",0,orlistat,,no
547,dojolvi,triheptanoin,triheptanoin,no,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,"InChI=1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3",0,triheptanoin,,no
548,epidiolex,cannabidiol,cannabidiol,no,C=C(C)C1CCC(C)=CC1c1c([O-])cc(CCCCC)cc1[O-],"InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/p-2",0,cannabidiol,,no
549,bylvay,odevixibat,odevixibat,no,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)NC(C(=O)NC(CC)C(=O)[O-])c3ccc([O-])cc3)cc2S(=O)(=O)N1,"InChI=1S/C37H48N4O8S2/c1-5-8-19-37(20-9-6-2)24-41(26-13-11-10-12-14-26)29-21-31(50-4)30(22-32(29)51(47,48)40-37)49-23-33(43)39-34(25-15-17-27(42)18-16-25)35(44)38-28(7-3)36(45)46/h10-18,21-22,28,34,40,42H,5-9,19-20,23-24H2,1-4H3,(H,38,44)(H,39,43)(H,45,46)/p-2",0,odevixibat,,no
550,propylthiouracil,propylthiouracil,propylthiouracil,no,CCCc1cc(=O)[n-]c(=S)[n-]1,"InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)/p-2",0,propylthiouracil,,no
551,trecator,ethionamide,ethionamide,no,CCc1cc(C([NH3+])=S)ccn1,"InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)/p+1",0,ethionamide,,no
552,ethosuximide,ethosuximide,ethosuximide,no,CCC1(C)CC(=O)NC1=O,"InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)",0,ethosuximide,,no
553,disulfiram,disulfiram,disulfiram,no,CC[NH+](CC)C(=S)SSC(=S)[NH+](CC)CC,"InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3/p+2",0,disulfiram,,no
554,purinethol,mercaptopurine,mercaptopurine,no,S=c1[n-]cnc2[n-]cnc12,"InChI=1S/C5H3N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H-,6,7,8,9,10)/q-1/p-1",0,mercaptopurine,,no
